<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Metformin - Wikipedia, the free encyclopedia</title>
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />
<meta name="generator" content="MediaWiki 1.23wmf19" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Metformin" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Metformin&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Metformin&amp;action=edit" />
<link rel="apple-touch-icon" href="//bits.wikimedia.org/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="//bits.wikimedia.org/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="http://en.wikipedia.org/wiki/Metformin" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.ui.button%7Cskins.common.interface%7Cskins.vector.styles&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: enwiki:resourceloader:filter:minify-css:7:3904d24a08aa08f6a68dc338f9be277e */</style>

<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Metformin","wgTitle":"Metformin","wgCurRevisionId":598885765,"wgRevisionId":598885765,"wgArticleId":253720,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Pages containing cite templates with deprecated parameters","Good articles","Articles containing unverified chemical infoboxes","Articles containing potentially dated statements from 2010","All articles containing potentially dated statements","Articles containing potentially dated statements from 2009","All articles with unsourced statements","Articles with unsourced statements from March 2011","Articles using fixed number of columns in reflist","Articles with Open Directory Project links","Guanidines","World Health Organization essential medicines","Biguanides"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Metformin","wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"templateEditor":false,"templates":false,"preview":false,"previewDialog":false,"publish":false,"toc":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"isPageWatched":false,"magnifyClipIconURL":"//bits.wikimedia.org/static-1.23wmf19/skins/common/images/magnify-clip.png","pageLanguageCode":"en","pageLanguageDir":"ltr","svgMaxSize":2048},"wikilove-recipient":"","wikilove-anon":0,"wgGuidedTourHelpGuiderUrl":"Help:Guided tours/guider","wgFlowTermsOfUseEdit":"By saving changes, you agree to our \u003Ca class=\"external text\" href=\"//wikimediafoundation.org/wiki/Terms_of_use\"\u003ETerms of Use\u003C/a\u003E and agree to irrevocably release your text under the \u003Ca rel=\"nofollow\" class=\"external text\" href=\"//creativecommons.org/licenses/by-sa/3.0\"\u003ECC BY-SA 3.0 License\u003C/a\u003E and \u003Ca class=\"external text\" href=\"//en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License\"\u003EGFDL\u003C/a\u003E","wgULSAcceptLanguageList":["en-gb"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q19484"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function(){mw.user.options.set({"ccmeonemails":0,"cols":80,"date":"default","diffonly":0,"disablemail":0,"editfont":"default","editondblclick":0,"editsectiononrightclick":0,"enotifminoredits":0,"enotifrevealaddr":0,"enotifusertalkpages":1,"enotifwatchlistpages":0,"extendwatchlist":0,"fancysig":0,"forceeditsummary":0,"gender":"unknown","hideminor":0,"hidepatrolled":0,"imagesize":2,"math":0,"minordefault":0,"newpageshidepatrolled":0,"nickname":"","norollbackdiff":0,"numberheadings":0,"previewonfirst":0,"previewontop":1,"rcdays":7,"rclimit":50,"rememberpassword":0,"rows":25,"showhiddencats":false,"shownumberswatching":1,"showtoolbar":1,"skin":"vector","stubthreshold":0,"thumbsize":4,"underline":2,"uselivepreview":0,"usenewrc":0,"watchcreations":1,"watchdefault":0,"watchdeletion":0,"watchlistdays":3,"watchlisthideanons":0,"watchlisthidebots":0,"watchlisthideliu":0,"watchlisthideminor":0,"watchlisthideown":0,"watchlisthidepatrolled":0,"watchmoves":0,
"wllimit":250,"useeditwarning":1,"prefershttps":1,"flaggedrevssimpleui":1,"flaggedrevsstable":0,"flaggedrevseditdiffs":true,"flaggedrevsviewdiffs":false,"usebetatoolbar":1,"usebetatoolbar-cgd":1,"visualeditor-enable":0,"visualeditor-enable-experimental":0,"visualeditor-betatempdisable":0,"wikilove-enabled":1,"echo-subscriptions-web-page-review":true,"echo-subscriptions-email-page-review":false,"ep_showtoplink":false,"ep_bulkdelorgs":false,"ep_bulkdelcourses":true,"ep_showdyk":true,"echo-subscriptions-web-education-program":true,"echo-subscriptions-email-education-program":false,"echo-notify-show-link":true,"echo-show-alert":true,"echo-email-frequency":0,"echo-email-format":"html","echo-subscriptions-email-system":true,"echo-subscriptions-web-system":true,"echo-subscriptions-email-other":false,"echo-subscriptions-web-other":true,"echo-subscriptions-email-edit-user-talk":false,"echo-subscriptions-web-edit-user-talk":true,"echo-subscriptions-email-reverted":false,
"echo-subscriptions-web-reverted":true,"echo-subscriptions-email-article-linked":false,"echo-subscriptions-web-article-linked":false,"echo-subscriptions-email-mention":false,"echo-subscriptions-web-mention":true,"echo-subscriptions-web-edit-thank":true,"echo-subscriptions-email-edit-thank":false,"echo-subscriptions-web-flow-discussion":true,"echo-subscriptions-email-flow-discussion":false,"gettingstarted-task-toolbar-show-intro":true,"uls-preferences":"","language":"en","variant-gan":"gan","variant-iu":"iu","variant-kk":"kk","variant-ku":"ku","variant-shi":"shi","variant-sr":"sr","variant-tg":"tg","variant-uz":"uz","variant-zh":"zh","searchNs0":true,"searchNs1":false,"searchNs2":false,"searchNs3":false,"searchNs4":false,"searchNs5":false,"searchNs6":false,"searchNs7":false,"searchNs8":false,"searchNs9":false,"searchNs10":false,"searchNs11":false,"searchNs12":false,"searchNs13":false,"searchNs14":false,"searchNs15":false,"searchNs100":false,"searchNs101":false,"searchNs108":false,
"searchNs109":false,"searchNs118":false,"searchNs119":false,"searchNs446":false,"searchNs447":false,"searchNs710":false,"searchNs711":false,"searchNs828":false,"searchNs829":false,"gadget-teahouse":1,"gadget-ReferenceTooltips":1,"gadget-DRN-wizard":1,"gadget-charinsert":1,"gadget-mySandbox":1,"variant":"en"});},{},{});mw.loader.implement("user.tokens",function(){mw.user.tokens.set({"editToken":"+\\","patrolToken":false,"watchToken":false});},{},{});
/* cache key: enwiki:resourceloader:filter:minify-js:7:868e43d07ede2616d2d1dc3507cd8145 */
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","skins.vector.compactPersonalBar.defaultTracking","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","wikibase.client.init","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" /><!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static-1.23wmf19/skins/vector/csshover.min.htc")}</style><![endif]--></head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Metformin skin-vector action-view vector-animateLayout">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>
			<div id="mw-js-message" style="display:none;"></div>
						<div id="siteNotice"><!-- CentralNotice --></div>
						<h1 id="firstHeading" class="firstHeading" lang="en"><span dir="auto">Metformin</span></h1>
						<div id="bodyContent">
								<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-navigation">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div style="display:none; right:10px;" class="metadata topicon nopopups" id="good-star"><a href="/wiki/Wikipedia:Good_articles" title="This is a good article. Click here for more information."><img alt="This is a good article. Click here for more information." src="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/15px-Symbol_support_vote.svg.png" width="15" height="15" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/23px-Symbol_support_vote.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/30px-Symbol_support_vote.svg.png 2x" /></a></div>
<table class="infobox" style="width: 22em">
<tr>
<th colspan="2" style="text-align: center"><a href="/wiki/File:Metformin.svg" class="image"><img alt="Metformin.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/46/Metformin.svg/200px-Metformin.svg.png" width="200" height="113" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/46/Metformin.svg/300px-Metformin.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/46/Metformin.svg/400px-Metformin.svg.png 2x" /></a></th>
</tr>
<tr>
<th colspan="2" style="text-align: center"><a href="/wiki/File:Metformin3Dan.gif" class="image"><img alt="Metformin3Dan.gif" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9d/Metformin3Dan.gif/200px-Metformin3Dan.gif" width="200" height="200" srcset="//upload.wikimedia.org/wikipedia/commons/9/9d/Metformin3Dan.gif 1.5x, //upload.wikimedia.org/wikipedia/commons/9/9d/Metformin3Dan.gif 2x" /></a></th>
</tr>
<tr>
<th colspan="2" style="background-color: #ddd; text-align: center">Systematic (<a href="/wiki/International_Union_of_Pure_and_Applied_Chemistry_nomenclature" title="International Union of Pure and Applied Chemistry nomenclature" class="mw-redirect">IUPAC</a>) name</th>
</tr>
<tr>
<td colspan="2" style="text-align: center"><span style="font-size:11px"><i>N</i>,<i>N</i>-Dimethylimidodicarbonimidic diamide</span></td>
</tr>
<tr>
<th colspan="2" style="background-color: #ddd; text-align: center">Clinical data</th>
</tr>
<tr>
<th><a href="/wiki/Trade_name" title="Trade name">Trade names</a></th>
<td>Glucophage</td>
</tr>
<tr>
<th><a href="/wiki/American_Society_of_Health-System_Pharmacists" title="American Society of Health-System Pharmacists">AHFS</a>/<a href="/wiki/Drugs.com" title="Drugs.com">Drugs.com</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.drugs.com/pro/metformin.html">FDA Professional Drug Information</a></span></td>
</tr>
<tr>
<th><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/druginfo/meds/a696005.html">a696005</a></span></td>
</tr>
<tr>
<th><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Licence data</a></th>
<td><a href="/wiki/U.S._Food_and_Drug_Administration" title="U.S. Food and Drug Administration" class="mw-redirect">US&#160;FDA</a>:<span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&amp;SearchTerm=metformin&amp;SearchType=BasicSearch">link</a></span></td>
</tr>
<tr>
<th><a href="/wiki/Pregnancy_category" title="Pregnancy category">Pregnancy cat.</a></th>
<td>C <small>(<a href="/wiki/Australia" title="Australia">AU</a>)</small> B <small>(<a href="/wiki/United_States" title="United States">US</a>)</small></td>
</tr>
<tr>
<th><a href="/wiki/Regulation_of_therapeutic_goods" title="Regulation of therapeutic goods">Legal status</a></th>
<td><a href="/wiki/Standard_for_the_Uniform_Scheduling_of_Drugs_and_Poisons#Schedule_4_Prescription_Only_Medicine" title="Standard for the Uniform Scheduling of Drugs and Poisons" class="mw-redirect">Prescription Only (S4)</a> <small>(<a href="/wiki/Australia" title="Australia">AU</a>)</small> <a href="/wiki/Prescription_drug" title="Prescription drug"><span class="Unicode">℞</span><small>-only</small></a> <small>(<a href="/wiki/Canada" title="Canada">CA</a>)</small> <a href="/wiki/Prescription_drug" title="Prescription drug">POM</a> <small>(<a href="/wiki/United_Kingdom" title="United Kingdom">UK</a>)</small> <a href="/wiki/Prescription_drug" title="Prescription drug"><span class="Unicode">℞</span><small>-only</small></a> <small>(<a href="/wiki/United_States" title="United States">US</a>)</small></td>
</tr>
<tr>
<th><a href="/wiki/Route_of_administration" title="Route of administration">Routes</a></th>
<td>oral</td>
</tr>
<tr>
<th colspan="2" style="background-color: #ddd; text-align: center">Pharmacokinetic data</th>
</tr>
<tr>
<th><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></th>
<td>50–60%<sup id="cite_ref-D95_1-0" class="reference"><a href="#cite_note-D95-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-D03_2-0" class="reference"><a href="#cite_note-D03-2"><span>[</span>2<span>]</span></a></sup></td>
</tr>
<tr>
<th><a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">Protein binding</a></th>
<td>Minimal<sup id="cite_ref-D95_1-1" class="reference"><a href="#cite_note-D95-1"><span>[</span>1<span>]</span></a></sup></td>
</tr>
<tr>
<th><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></th>
<td>Not by liver<sup id="cite_ref-D95_1-2" class="reference"><a href="#cite_note-D95-1"><span>[</span>1<span>]</span></a></sup></td>
</tr>
<tr>
<th><a href="/wiki/Biological_half-life" title="Biological half-life">Half-life</a></th>
<td>4-8.7 hours<sup id="cite_ref-D95_1-3" class="reference"><a href="#cite_note-D95-1"><span>[</span>1<span>]</span></a></sup></td>
</tr>
<tr>
<th><a href="/wiki/Excretion" title="Excretion">Excretion</a></th>
<td>Urine (90%)<sup id="cite_ref-D95_1-4" class="reference"><a href="#cite_note-D95-1"><span>[</span>1<span>]</span></a></sup></td>
</tr>
<tr>
<th colspan="2" style="background-color: #ddd; text-align: center">Identifiers</th>
</tr>
<tr>
<th><a href="/wiki/CAS_registry_number" title="CAS registry number">CAS number</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=657-24-9&amp;rn=1">657-24-9</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th><a href="/wiki/Anatomical_Therapeutic_Chemical_Classification_System" title="Anatomical Therapeutic Chemical Classification System">ATC code</a></th>
<td><a href="/wiki/ATC_code_A10" title="ATC code A10">A10</a><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.whocc.no/atc_ddd_index/?code=A10BA02">BA02</a></span></td>
</tr>
<tr>
<th><a href="/wiki/PubChem" title="PubChem">PubChem</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4091">CID 4091</a></span></td>
</tr>
<tr>
<th><a href="/wiki/DrugBank" title="DrugBank">DrugBank</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.drugbank.ca/drugs/DB00331">DB00331</a></span></td>
</tr>
<tr>
<th><a href="/wiki/ChemSpider" title="ChemSpider">ChemSpider</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.chemspider.com/Chemical-Structure.3949">3949</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th><a href="/wiki/Unique_Ingredient_Identifier" title="Unique Ingredient Identifier">UNII</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=9100L32L2N">9100L32L2N</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th><a href="/wiki/KEGG" title="KEGG">KEGG</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="http://www.kegg.jp/entry/D04966">D04966</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th><a href="/wiki/ChEBI" title="ChEBI">ChEBI</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6801">CHEBI:6801</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th><a href="/wiki/ChEMBL" title="ChEMBL">ChEMBL</a></th>
<td><span class="reflink plainlinks nourlexpansion"><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1431">CHEMBL1431</a></span><sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></td>
</tr>
<tr>
<th colspan="2" style="background-color: #ddd; text-align: center">Chemical data</th>
</tr>
<tr>
<th><a href="/wiki/Chemical_formula" title="Chemical formula">Formula</a></th>
<td><a href="/wiki/Carbon" title="Carbon"><span style="color: rgb(000,000,000); font-weight: bold;">C</span></a><sub>4</sub><a href="/wiki/Hydrogen" title="Hydrogen"><span style="color: rgb(77,77,77); font-weight: bold;">H</span></a><sub>11</sub><a href="/wiki/Nitrogen" title="Nitrogen"><span style="color: rgb(0,0,128); font-weight: bold;">N</span></a><sub>5</sub><sup>&#160;</sup></td>
</tr>
<tr>
<th><a href="/wiki/Molecular_mass" title="Molecular mass">Mol. mass</a></th>
<td>129.16364</td>
</tr>
<tr>
<td colspan="2">
<div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;"><a href="/wiki/Simplified_molecular_input_line_entry_specification" title="Simplified molecular input line entry specification" class="mw-redirect">SMILES</a></div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;">
<li style="line-height: inherit; margin: 0">C[n](C):c(:[nH]):[nH]:c(:[nH]):[nH2]</li>
</ul>
</div>
</td>
</tr>
<tr>
<td colspan="2">
<div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;"><a href="/wiki/International_Chemical_Identifier" title="International Chemical Identifier">InChI</a></div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;">
<li style="line-height: inherit; margin: 0">
<p style="word-wrap: break-word;">InChI=1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8)<br />
Key:XZWYZXLIPXDOLR-UHFFFAOYSA-N<sup>&#160;<img alt="Yes" src="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png" width="7" height="7" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/11px-Yes_check.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/14px-Yes_check.svg.png 2x" /><span style="display:none">Y</span></sup></p>
</li>
</ul>
</div>
</td>
</tr>
</table>
<p><b>Metformin</b> (<a href="/wiki/British_Approved_Name" title="British Approved Name">BAN</a>, <a href="/wiki/United_States_Adopted_Name" title="United States Adopted Name">USAN</a> and <a href="/wiki/International_Nonproprietary_Name" title="International Nonproprietary Name">INN</a>, pronounced <span class="nowrap"><span title="Representation in the International Phonetic Alphabet (IPA)" class="IPA"><a href="/wiki/Help:IPA_for_English" title="Help:IPA for English">/</a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="'m' in 'my'" style="border-bottom:1px dotted">m</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="/ɛ/ short 'e' in 'bed'" style="border-bottom:1px dotted">ɛ</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="'t' in 'tie'" style="border-bottom:1px dotted">t</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="/ˈ/ primary stress follows" style="border-bottom:1px dotted">ˈ</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="'f' in 'find'" style="border-bottom:1px dotted">f</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="/ɔr/ 'or' in 'born'" style="border-bottom:1px dotted">ɔr</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="'m' in 'my'" style="border-bottom:1px dotted">m</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="/ɨ/ 'e' in 'roses'" style="border-bottom:1px dotted">ɨ</span></a></span><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English#Key" title="Help:IPA for English"><span title="'n' in 'nigh'" style="border-bottom:1px dotted">n</span></a></span><span title="Representation in the International Phonetic Alphabet (IPA)" class="IPA"><a href="/wiki/Help:IPA_for_English" title="Help:IPA for English">/</a></span></span>, <span title="English pronunciation respelling" class="Unicode"><a href="/wiki/Wikipedia:Pronunciation_respelling_key" title="Wikipedia:Pronunciation respelling key"><i>met-<b><span class="smallcaps"><span class="SMALLCAPS" style="FONT-VARIANT:SMALL-CAPS;"><span class="NOCAPS" style="TEXT-TRANSFORM:LOWERCASE;">FAWR</span></span></span></b>-min</i></a></span>; sold as <b>Glucophage</b>) is an oral <a href="/wiki/Antidiabetic_drug" title="Antidiabetic drug" class="mw-redirect">antidiabetic drug</a> in the <a href="/wiki/Biguanide" title="Biguanide">biguanide</a> class. It is the <a href="/wiki/First-line_treatment" title="First-line treatment" class="mw-redirect">first-line</a> drug of choice for the treatment of <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">type 2 diabetes</a>, in particular, in <a href="/wiki/Overweight" title="Overweight">overweight</a> and <a href="/wiki/Obesity" title="Obesity">obese</a> people and those with normal kidney function.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-NICErecommendations_4-0" class="reference"><a href="#cite_note-NICErecommendations-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-ADAstandardsOfCare_5-0" class="reference"><a href="#cite_note-ADAstandardsOfCare-5"><span>[</span>5<span>]</span></a></sup> Its use in <a href="/wiki/Gestational_diabetes" title="Gestational diabetes">gestational diabetes</a> has been limited by safety concerns. It is also used in the treatment of <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a>, and has been investigated for other diseases where <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a> may be an important factor. Metformin works by suppressing glucose production by the liver.</p>
<p>Metformin is the only antidiabetic drug that has been conclusively shown to prevent the cardiovascular complications of diabetes. It helps reduce <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL cholesterol</a> and <a href="/wiki/Triglyceride" title="Triglyceride">triglyceride</a> levels, and is not associated with weight gain. As of 2010<sup class="plainlinks noprint asof-tag update" style="display:none;"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Metformin&amp;action=edit">[update]</a></sup>, metformin is one of only two oral antidiabetics in the <a href="/wiki/World_Health_Organization_Model_List_of_Essential_Medicines" title="World Health Organization Model List of Essential Medicines" class="mw-redirect">World Health Organization Model List of Essential Medicines</a> (the other being <a href="/wiki/Glibenclamide" title="Glibenclamide">glibenclamide</a>).<sup id="cite_ref-WHOessential_6-0" class="reference"><a href="#cite_note-WHOessential-6"><span>[</span>6<span>]</span></a></sup></p>
<p>Metformin causes few <a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">adverse effects</a> when prescribed appropriately (the most common is gastrointestinal upset) and has been associated with a low risk of <a href="/wiki/Hypoglycemia" title="Hypoglycemia">hypoglycemia</a>. <a href="/wiki/Lactic_acidosis" title="Lactic acidosis">Lactic acidosis</a> (a buildup of <a href="/wiki/Lactic_acid" title="Lactic acid">lactate</a> in the blood) can be a serious concern in <a href="/wiki/Overdose" title="Overdose" class="mw-redirect">overdose</a> and when it is prescribed to people with <a href="/wiki/Contraindication" title="Contraindication">contraindications</a>, but otherwise, there is no <a href="/wiki/Statistical_significance" title="Statistical significance">significant</a> risk.<sup id="cite_ref-pmid21617112_7-0" class="reference"><a href="#cite_note-pmid21617112-7"><span>[</span>7<span>]</span></a></sup></p>
<p>First <a href="/wiki/Chemical_synthesis" title="Chemical synthesis">synthesized</a> and found to reduce blood sugar in the 1920s, metformin was forgotten for the next two decades as research shifted to <a href="/wiki/Insulin" title="Insulin">insulin</a> and other antidiabetic drugs. Interest in metformin was rekindled in the late 1940s after several reports that it could reduce blood sugar levels in people, and in 1957, French physician Jean Sterne published the first <a href="/wiki/Clinical_trial" title="Clinical trial">clinical trial</a> of metformin as a treatment for diabetes. It was introduced to the United Kingdom in 1958, Canada in 1972, and the United States in 1995. Metformin is now believed to be the most widely prescribed antidiabetic drug in the world; in the United States alone, more than 48 million prescriptions were filled in 2010 for its <a href="/wiki/Generic_drug" title="Generic drug">generic formulations</a>.<sup id="cite_ref-Bailey_8-0" class="reference"><a href="#cite_note-Bailey-8"><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-Top200Generics_9-0" class="reference"><a href="#cite_note-Top200Generics-9"><span>[</span>9<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Medical_uses"><span class="tocnumber">1</span> <span class="toctext">Medical uses</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Type_2_diabetes"><span class="tocnumber">1.1</span> <span class="toctext">Type 2 diabetes</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Prediabetes"><span class="tocnumber">1.2</span> <span class="toctext">Prediabetes</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Polycystic_ovary_syndrome"><span class="tocnumber">1.3</span> <span class="toctext">Polycystic ovary syndrome</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Gestational_diabetes"><span class="tocnumber">1.4</span> <span class="toctext">Gestational diabetes</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-6"><a href="#Contraindications"><span class="tocnumber">2</span> <span class="toctext">Contraindications</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Adverse_effects"><span class="tocnumber">3</span> <span class="toctext">Adverse effects</span></a>
<ul>
<li class="toclevel-2 tocsection-8"><a href="#Gastrointestinal"><span class="tocnumber">3.1</span> <span class="toctext">Gastrointestinal</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Lactic_acidosis"><span class="tocnumber">3.2</span> <span class="toctext">Lactic acidosis</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Overdose"><span class="tocnumber">3.3</span> <span class="toctext">Overdose</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Interactions"><span class="tocnumber">3.4</span> <span class="toctext">Interactions</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Mechanism_of_action"><span class="tocnumber">4</span> <span class="toctext">Mechanism of action</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#Chemistry"><span class="tocnumber">5</span> <span class="toctext">Chemistry</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#Structure"><span class="tocnumber">6</span> <span class="toctext">Structure</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#Pharmacokinetics"><span class="tocnumber">7</span> <span class="toctext">Pharmacokinetics</span></a></li>
<li class="toclevel-1 tocsection-16"><a href="#History"><span class="tocnumber">8</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#Formulations"><span class="tocnumber">9</span> <span class="toctext">Formulations</span></a>
<ul>
<li class="toclevel-2 tocsection-18"><a href="#Combinations_with_other_drugs"><span class="tocnumber">9.1</span> <span class="toctext">Combinations with other drugs</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-19"><a href="#Research"><span class="tocnumber">10</span> <span class="toctext">Research</span></a></li>
<li class="toclevel-1 tocsection-20"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-21"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Medical_uses">Medical uses</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=1" title="Edit section: Medical uses">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Metformin is primarily used for type 2 diabetes, but is increasingly being used in <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a> (PCOS),<sup id="cite_ref-Lord_10-0" class="reference"><a href="#cite_note-Lord-10"><span>[</span>10<span>]</span></a></sup> <a href="/wiki/Non-alcoholic_fatty_liver_disease" title="Non-alcoholic fatty liver disease">non-alcoholic fatty liver disease</a> (NAFLD)<sup id="cite_ref-Marchesini_11-0" class="reference"><a href="#cite_note-Marchesini-11"><span>[</span>11<span>]</span></a></sup> and premature puberty,<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup> three other diseases that feature <a href="/wiki/Insulin_resistance" title="Insulin resistance">insulin resistance</a>; these indications are still<sup class="plainlinks noprint asof-tag update" style="display:none;"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Metformin&amp;action=edit">[update]</a></sup> considered experimental. The benefit of metformin in NAFLD has not been extensively studied and may be only temporary;<sup id="cite_ref-Nair_13-0" class="reference"><a href="#cite_note-Nair-13"><span>[</span>13<span>]</span></a></sup> although some <a href="/wiki/Randomized_controlled_trial" title="Randomized controlled trial">randomized controlled trials</a> have found significant improvement with its use, the evidence is still insufficient.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Type_2_diabetes">Type 2 diabetes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=2" title="Edit section: Type 2 diabetes">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The main use for metformin is in the treatment of <a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">diabetes mellitus</a> type 2, especially in <a href="/wiki/Overweight" title="Overweight">overweight</a> people. In this group, over 10 years of treatment, metformin reduced diabetes complications and overall mortality by about 30% when compared with <a href="/wiki/Insulin" title="Insulin">insulin</a> and <a href="/wiki/Sulfonylurea" title="Sulfonylurea">sulfonylureas</a> (<a href="/wiki/Glibenclamide" title="Glibenclamide">glibenclamide</a> and <a href="/wiki/Chlorpropamide" title="Chlorpropamide">chlorpropamide</a>) and by about 40% when compared with the group only given dietary advice.<sup id="cite_ref-UKPDS_16-0" class="reference"><a href="#cite_note-UKPDS-16"><span>[</span>16<span>]</span></a></sup> This difference held in people who were followed up for five to 10 years after the study.<sup id="cite_ref-pmid18784090_17-0" class="reference"><a href="#cite_note-pmid18784090-17"><span>[</span>17<span>]</span></a></sup> Since intensive glucose control with metformin appears to decrease the risk of diabetes-related endpoints in overweight people with diabetes, and is associated with less weight gain and fewer hypoglycaemic attacks than are insulin and sulphonylureas, it may be the first-line pharmacological therapy of choice in this group. In addition, metformin had no effect on body weight: Over the 10-year treatment period, the metformin group gained about 1&#160;kg, the same as the dietary advice group, while the sulfonylureas group gained 3&#160;kg, and the insulin group, 6&#160;kg.<sup id="cite_ref-UKPDS_16-1" class="reference"><a href="#cite_note-UKPDS-16"><span>[</span>16<span>]</span></a></sup><sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> As metformin affords a similar level of <a href="/wiki/Blood_sugar" title="Blood sugar">blood sugar</a> control to insulin and sulfonylureas, it appears to decrease mortality primarily through decreasing heart attacks, strokes and other cardiovascular complications.</p>
<p>Metformin has a lower risk of hypoglycemia than the sulfonylureas,<sup id="cite_ref-Umesh_19-0" class="reference"><a href="#cite_note-Umesh-19"><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-Bolen_20-0" class="reference"><a href="#cite_note-Bolen-20"><span>[</span>20<span>]</span></a></sup> although it has uncommonly occurred during intense exercise, calorie deficit, or when used with other agents to lower blood glucose.<sup id="cite_ref-isbn0071416137_21-0" class="reference"><a href="#cite_note-isbn0071416137-21"><span>[</span>21<span>]</span></a></sup><sup id="cite_ref-22" class="reference"><a href="#cite_note-22"><span>[</span>22<span>]</span></a></sup> Metformin is also not associated with weight gain, and modestly reduces <a href="/wiki/Low_density_lipoprotein" title="Low density lipoprotein" class="mw-redirect">LDL</a> and <a href="/wiki/Triglyceride" title="Triglyceride">triglyceride</a> levels.<sup id="cite_ref-Umesh_19-1" class="reference"><a href="#cite_note-Umesh-19"><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-Bolen_20-1" class="reference"><a href="#cite_note-Bolen-20"><span>[</span>20<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Prediabetes">Prediabetes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=3" title="Edit section: Prediabetes">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Metformin treatment of people at risk for type 2 diabetes may decrease their chances of developing the disease, although intensive physical exercise and dieting work significantly better for this purpose. In a large U.S. study known as the Diabetes Prevention Program, participants were divided into groups and given either placebo, metformin, or lifestyle intervention, and followed for an average of three years. The intensive program of lifestyle modifications included a 16-lesson training on dieting and exercise followed by monthly individualized sessions with the goals to decrease the body weight by 7% and engage in a physical activity for at least 150 minutes per week. The <a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">incidence</a> of diabetes was 58% lower in the lifestyle group and 31% lower in those given metformin. Among younger people with a higher body mass index, lifestyle modification was no more effective than metformin, and for older individuals with a lower body mass index, metformin was no better than placebo in preventing diabetes.<sup id="cite_ref-DPP_23-0" class="reference"><a href="#cite_note-DPP-23"><span>[</span>23<span>]</span></a></sup> After ten years, the incidence of diabetes was 34% lower in the group of participants given diet and exercise and 18% lower in those given metformin.<sup id="cite_ref-DPP10_24-0" class="reference"><a href="#cite_note-DPP10-24"><span>[</span>24<span>]</span></a></sup> It is unclear whether metformin slowed down the progression of prediabetes to diabetes (true preventive effect), or the decrease of diabetes in the treated population was simply due to its glucose-lowering action (treatment effect).<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Polycystic_ovary_syndrome">Polycystic ovary syndrome</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=4" title="Edit section: Polycystic ovary syndrome">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Antidiabetic therapy has been proposed as a treatment for <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a> (PCOS), a condition frequently associated with insulin resistance, since the late 1980s.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26"><span>[</span>26<span>]</span></a></sup> The use of metformin in PCOS was first reported in 1994, in a small study conducted at the <a href="/wiki/University_of_the_Andes,_Venezuela" title="University of the Andes, Venezuela" class="mw-redirect">University of the Andes, Venezuela</a>.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-Teede_28-0" class="reference"><a href="#cite_note-Teede-28"><span>[</span>28<span>]</span></a></sup> The United Kingdom's <a href="/wiki/National_Institute_for_Health_and_Clinical_Excellence" title="National Institute for Health and Clinical Excellence" class="mw-redirect">National Institute for Health and Clinical Excellence</a> recommended in 2004 that women with PCOS and a <a href="/wiki/Body_mass_index" title="Body mass index">body mass index</a> above 25 be given metformin for <a href="/wiki/Anovulation" title="Anovulation">anovulation</a> and <a href="/wiki/Infertility" title="Infertility">infertility</a> when other therapies have failed to produce results.<sup id="cite_ref-NICEfertility_29-0" class="reference"><a href="#cite_note-NICEfertility-29"><span>[</span>29<span>]</span></a></sup> However, two clinical studies completed in 2006–2007 returned mostly negative results, with metformin being no better than placebo, and a metformin-<a href="/wiki/Clomifene" title="Clomifene">clomifene</a> combination no better than clomifene alone.<sup id="cite_ref-pmid17287476_30-0" class="reference"><a href="#cite_note-pmid17287476-30"><span>[</span>30<span>]</span></a></sup><sup id="cite_ref-pmid16769748_31-0" class="reference"><a href="#cite_note-pmid16769748-31"><span>[</span>31<span>]</span></a></sup> Reflecting this, subsequent reviews noted large randomized controlled trials have, in general, not shown the promise suggested by the early small studies. UK and international <a href="/wiki/Clinical_practice_guideline" title="Clinical practice guideline" class="mw-redirect">clinical practice guidelines</a> do not recommend metformin as a first-line treatment<sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup> or do not recommend it at all, except for women with <a href="/wiki/Glucose_intolerance" title="Glucose intolerance" class="mw-redirect">glucose intolerance</a>.<sup id="cite_ref-pmid18308833_33-0" class="reference"><a href="#cite_note-pmid18308833-33"><span>[</span>33<span>]</span></a></sup> The guidelines suggest clomiphene as the first medication option and emphasize lifestyle modification independently from the drug treatment.</p>
<p>In a dissenting opinion, a systematic review of four head-to-head comparative trials of metformin and clomifene found them equally effective for infertility.<sup id="cite_ref-pmid18691273_34-0" class="reference"><a href="#cite_note-pmid18691273-34"><span>[</span>34<span>]</span></a></sup> A BMJ editorial noted four positive studies of metformin were in people not responding to clomifene, while the population in the negative studies was drug-naive or uncontrolled for the previous treatment. The editorial suggested metformin should be used as a second-line drug if clomifene treatment fails.<sup id="cite_ref-pmid16793784_35-0" class="reference"><a href="#cite_note-pmid16793784-35"><span>[</span>35<span>]</span></a></sup> Another review recommended metformin unreservedly as a first-line treatment option because it has positive effects not only on anovulation, but also on insulin resistance, hirsutism, and obesity often associated with PCOS.<sup id="cite_ref-pmid19405411_36-0" class="reference"><a href="#cite_note-pmid19405411-36"><span>[</span>36<span>]</span></a></sup> A <a href="/wiki/Cochrane_Collaboration" title="Cochrane Collaboration">Cochrane Collaboration</a> review found metformin improves ovulation and pregnancy rates, particularly when combined with <a href="/wiki/Clomifene" title="Clomifene">clomifene</a>, but is not associated with any increase in the number of live births.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37"><span>[</span>37<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Gestational_diabetes">Gestational diabetes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=5" title="Edit section: Gestational diabetes">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Several <a href="/wiki/Observational_study" title="Observational study">observational studies</a> and randomized, controlled trials have found metformin is as effective and safe as insulin for the management of gestational diabetes,<sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span>[</span>38<span>]</span></a></sup><sup id="cite_ref-MiG_39-0" class="reference"><a href="#cite_note-MiG-39"><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-Nicholson_40-0" class="reference"><a href="#cite_note-Nicholson-40"><span>[</span>40<span>]</span></a></sup> and a small <a href="/wiki/Case-control_study" title="Case-control study">case-control study</a> has suggested the children of women given metformin instead of insulin may be healthier in the <a href="/wiki/Infant" title="Infant">neonatal</a> period.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41"><span>[</span>41<span>]</span></a></sup> Nonetheless, several concerns have been raised regarding studies published thus far, and evidence on the long-term safety of metformin for both mother and child is still lacking.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42"><span>[</span>42<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Contraindications">Contraindications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=6" title="Edit section: Contraindications">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Metformin is <a href="/wiki/Contraindication" title="Contraindication">contraindicated</a> in people with any condition that could increase the risk of <a href="/wiki/Lactic_acidosis" title="Lactic acidosis">lactic acidosis</a>, including <a href="/wiki/Kidney" title="Kidney">kidney</a> disorders (<a href="/wiki/Creatinine" title="Creatinine">creatinine</a> levels over 150 μmol/l (1.7&#160;mg/dL),<sup id="cite_ref-Jones2003_43-0" class="reference"><a href="#cite_note-Jones2003-43"><span>[</span>43<span>]</span></a></sup> although this is an arbitrary limit), <a href="/wiki/Lung_disease" title="Lung disease" class="mw-redirect">lung disease</a> and <a href="/wiki/Liver_disease" title="Liver disease">liver disease</a>. According to the <a href="/wiki/Package_insert" title="Package insert">prescribing information</a>, <a href="/wiki/Heart_failure" title="Heart failure">heart failure</a> (in particular, unstable or acute congestive heart failure) increases the risk of lactic acidosis with metformin.<sup id="cite_ref-glucopi_44-0" class="reference"><a href="#cite_note-glucopi-44"><span>[</span>44<span>]</span></a></sup> A 2007 <a href="/wiki/Systematic_review" title="Systematic review">systematic review</a> of controlled trials, however, suggested metformin is the only antidiabetic drug not associated with any measurable harm in people with heart failure, and that it may reduce mortality in comparison with other antidiabetic agents.<sup id="cite_ref-Eurich_45-0" class="reference"><a href="#cite_note-Eurich-45"><span>[</span>45<span>]</span></a></sup></p>
<p>Metformin is recommended to be temporarily discontinued before any <a href="/wiki/Medical_imaging" title="Medical imaging">radiographic study</a> involving <a href="/wiki/Iodine" title="Iodine">iodinated</a> <a href="/wiki/Radiocontrast" title="Radiocontrast" class="mw-redirect">contrast</a> agents, (such as a contrast-enhanced <a href="/wiki/Computed_tomography" title="Computed tomography" class="mw-redirect">CT scan</a> or <a href="/wiki/Angiogram" title="Angiogram" class="mw-redirect">angiogram</a>), as the contrast dye may temporarily impair kidney function, indirectly leading to lactic acidosis by causing retention of metformin in the body.<sup id="cite_ref-RCR_46-0" class="reference"><a href="#cite_note-RCR-46"><span>[</span>46<span>]</span></a></sup><sup id="cite_ref-ESUR_47-0" class="reference"><a href="#cite_note-ESUR-47"><span>[</span>47<span>]</span></a></sup> Metformin can be resumed after two days, assuming kidney function is normal.<sup id="cite_ref-RCR_46-1" class="reference"><a href="#cite_note-RCR-46"><span>[</span>46<span>]</span></a></sup><sup id="cite_ref-ESUR_47-1" class="reference"><a href="#cite_note-ESUR-47"><span>[</span>47<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Adverse_effects">Adverse effects</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=7" title="Edit section: Adverse effects">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The most common <a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">adverse effect</a> of metformin is gastrointestinal irritation, including <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a>, cramps, nausea, vomiting and increased <a href="/wiki/Flatulence" title="Flatulence">flatulence</a>; metformin is more commonly associated with gastrointestinal side effects than most other antidiabetic drugs.<sup id="cite_ref-Bolen_20-2" class="reference"><a href="#cite_note-Bolen-20"><span>[</span>20<span>]</span></a></sup> The most serious potential side effect of metformin use is <a href="/wiki/Lactic_acidosis" title="Lactic acidosis">lactic acidosis</a>; this complication is very rare, and the vast majority of these cases seem to be related to comorbid conditions, such as impaired liver or kidney function, rather than to the metformin itself.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup></p>
<p>Metformin has also been reported to decrease the blood levels of <a href="/wiki/Thyroid-stimulating_hormone" title="Thyroid-stimulating hormone">thyroid-stimulating hormone</a> in people with <a href="/wiki/Hypothyroidism" title="Hypothyroidism">hypothyroidism</a>,<sup id="cite_ref-49" class="reference"><a href="#cite_note-49"><span>[</span>49<span>]</span></a></sup> The clinical significance of this is still unknown.</p>
<h3><span class="mw-headline" id="Gastrointestinal">Gastrointestinal</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=8" title="Edit section: Gastrointestinal">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In a clinical trial of 286 subjects, 53.2% of the 141 given immediate-release metformin (as opposed to <a href="/wiki/Placebo" title="Placebo">placebo</a>) reported diarrhea, versus 11.7% for placebo, and 25.5% reported nausea/vomiting, versus 8.3% for those on placebo.<sup id="cite_ref-DF.26C_50-0" class="reference"><a href="#cite_note-DF.26C-50"><span>[</span>50<span>]</span></a></sup></p>
<p>Gastrointestinal upset can cause severe discomfort; it is most common when metformin is first administered, or when the dose is increased. The discomfort can often be avoided by beginning at a low dose (1 to 1.7&#160;grams per day) and increasing the dose gradually. Gastrointestinal upset after prolonged, steady use is less common.<sup class="Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (March 2011)">citation needed</span></a></i>]</sup></p>
<p>Long-term use of metformin has been associated with increased <a href="/wiki/Homocysteine" title="Homocysteine">homocysteine</a> levels<sup id="cite_ref-Wulffele_51-0" class="reference"><a href="#cite_note-Wulffele-51"><span>[</span>51<span>]</span></a></sup> and <a href="/wiki/Malabsorption" title="Malabsorption">malabsorption</a> of <a href="/wiki/Cyanocobalamin" title="Cyanocobalamin">vitamin B<sub>12</sub></a>.<sup id="cite_ref-Andres_52-0" class="reference"><a href="#cite_note-Andres-52"><span>[</span>52<span>]</span></a></sup><sup id="cite_ref-Gilligan_53-0" class="reference"><a href="#cite_note-Gilligan-53"><span>[</span>53<span>]</span></a></sup> Higher doses and prolonged use are associated with increased incidence of vitamin B<sub>12</sub> deficiency,<sup id="cite_ref-54" class="reference"><a href="#cite_note-54"><span>[</span>54<span>]</span></a></sup> and some researchers recommend screening or prevention strategies.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55"><span>[</span>55<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Lactic_acidosis">Lactic acidosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=9" title="Edit section: Lactic acidosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The most serious potential adverse effect of biguanide use is <a href="/wiki/Lactic_acidosis" title="Lactic acidosis">lactic acidosis</a> ("metformin-associated lactic acidosis" or MALA), the incidence for which is 9 per 100,000 person-years.<sup id="cite_ref-Stang_56-0" class="reference"><a href="#cite_note-Stang-56"><span>[</span>56<span>]</span></a></sup> <a href="/wiki/Phenformin" title="Phenformin">Phenformin</a>, another biguanide, was withdrawn from the market because of an increased risk of lactic acidosis (rate of 40-64 per 100,000 patient-years).<sup id="cite_ref-Stang_56-1" class="reference"><a href="#cite_note-Stang-56"><span>[</span>56<span>]</span></a></sup> However, metformin is safer than phenformin, and the risk of developing lactic acidosis is not increased by the medication as long as it is not prescribed to known high-risk groups.<sup id="cite_ref-Salpeter_57-0" class="reference"><a href="#cite_note-Salpeter-57"><span>[</span>57<span>]</span></a></sup></p>
<p>Lactate uptake by the liver is diminished with metformin administration because lactate is a substrate for hepatic <a href="/wiki/Gluconeogenesis" title="Gluconeogenesis">gluconeogenesis</a>, a process that metformin inhibits. In healthy individuals, this slight excess is simply cleared by other mechanisms (including uptake by the kidneys, when their function is unimpaired), and no significant elevation in blood levels of lactate occurs.<sup id="cite_ref-Umesh_19-2" class="reference"><a href="#cite_note-Umesh-19"><span>[</span>19<span>]</span></a></sup> When there is impaired renal function, however, clearance of metformin and lactate is reduced, leading to increased levels of both, and possibly causing lactic acidosis due to a buildup of lactic acid. Because metformin decreases liver uptake of lactate, any condition that may precipitate lactic acidosis is a contraindication to its use. Common causes of increased lactic acid production include <a href="/wiki/Alcoholism" title="Alcoholism">alcoholism</a> (due to depletion of <a href="/wiki/Nicotinamide_adenine_dinucleotide" title="Nicotinamide adenine dinucleotide">NAD+</a> stores), heart failure, and respiratory disease (due to inadequate oxygenation of tissues); the most common cause of impaired lactic acid excretion is kidney disease.<sup id="cite_ref-Golan_58-0" class="reference"><a href="#cite_note-Golan-58"><span>[</span>58<span>]</span></a></sup></p>
<p>Metformin has also been suggested to increase production of lactate in the small intestine; this could potentially contribute to lactic acidosis in those with risk factors.<sup id="cite_ref-Kirpichnikov_59-0" class="reference"><a href="#cite_note-Kirpichnikov-59"><span>[</span>59<span>]</span></a></sup> However, the clinical significance of this is unknown, and the risk of metformin-associated lactic acidosis is most commonly attributed to decreased hepatic uptake rather than increased intestinal production.<sup id="cite_ref-Umesh_19-3" class="reference"><a href="#cite_note-Umesh-19"><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-Golan_58-1" class="reference"><a href="#cite_note-Golan-58"><span>[</span>58<span>]</span></a></sup><sup id="cite_ref-60" class="reference"><a href="#cite_note-60"><span>[</span>60<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Overdose">Overdose</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=10" title="Edit section: Overdose">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>A review of intentional and accidental metformin overdoses reported to <a href="/wiki/Poison_control_center" title="Poison control center">poison control centers</a> over a five-year period found serious adverse events were rare, though the elderly appeared to be at greater risk.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61"><span>[</span>61<span>]</span></a></sup> A similar study where cases were reported to Texas poison control centers between the years 2000 and 2006 found ingested doses of more than 5,000&#160;mg were more likely to involve serious medical outcomes in adults.<sup id="cite_ref-Forrester_62-0" class="reference"><a href="#cite_note-Forrester-62"><span>[</span>62<span>]</span></a></sup> Survival following intentional overdoses with up to 63,000&#160;mg (63&#160;g) of metformin have been reported in the medical literature.<sup id="cite_ref-63g_63-0" class="reference"><a href="#cite_note-63g-63"><span>[</span>63<span>]</span></a></sup> Fatalities following overdose are rare, but do occur.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64"><span>[</span>64<span>]</span></a></sup><sup id="cite_ref-Suchard_65-0" class="reference"><a href="#cite_note-Suchard-65"><span>[</span>65<span>]</span></a></sup><sup id="cite_ref-Teale_66-0" class="reference"><a href="#cite_note-Teale-66"><span>[</span>66<span>]</span></a></sup> In healthy children, unintentional doses of less than 1,700&#160;mg are unlikely to cause any significant toxic effects.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67"><span>[</span>67<span>]</span></a></sup></p>
<p>The most common symptoms following overdose appear to include <a href="/wiki/Vomiting" title="Vomiting">vomiting</a>, <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a>, <a href="/wiki/Abdominal_pain" title="Abdominal pain">abdominal pain</a>, <a href="/wiki/Tachycardia" title="Tachycardia">tachycardia</a>, drowsiness, and, rarely, <a href="/wiki/Hypoglycemia" title="Hypoglycemia">hypoglycemia</a> or <a href="/wiki/Hyperglycemia" title="Hyperglycemia">hyperglycemia</a>.<sup id="cite_ref-Forrester_62-1" class="reference"><a href="#cite_note-Forrester-62"><span>[</span>62<span>]</span></a></sup><sup id="cite_ref-Suchard_65-1" class="reference"><a href="#cite_note-Suchard-65"><span>[</span>65<span>]</span></a></sup> The major potentially life-threatening complication of metformin overdose is lactic acidosis, which is due to lactate accumulation.<sup id="cite_ref-68" class="reference"><a href="#cite_note-68"><span>[</span>68<span>]</span></a></sup><sup id="cite_ref-69" class="reference"><a href="#cite_note-69"><span>[</span>69<span>]</span></a></sup> Treatment of metformin overdose is generally supportive, as there is no specific antidote. Lactic acidosis is initially treated with <a href="/wiki/Sodium_bicarbonate" title="Sodium bicarbonate">sodium bicarbonate</a>, although high doses are not recommended, as this may increase <a href="/wiki/Intracellular" title="Intracellular">intracellular</a> acidosis.<sup id="cite_ref-Teale_66-1" class="reference"><a href="#cite_note-Teale-66"><span>[</span>66<span>]</span></a></sup> Acidosis that does not respond to administration of sodium bicarbonate may require further management with <a href="/wiki/Hemodialysis" title="Hemodialysis">standard hemodialysis</a> or <a href="/wiki/Hemofiltration" title="Hemofiltration">continuous veno-venous hemofiltration</a>. In addition, due to metformin’s low <a href="/wiki/Molecular_weight" title="Molecular weight" class="mw-redirect">molecular weight</a> and lack of <a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">plasma protein binding</a>, these techniques also have the benefit of efficiently removing metformin from <a href="/wiki/Blood_plasma" title="Blood plasma">blood plasma</a>, preventing further lactate overproduction.<sup id="cite_ref-cvvh_70-0" class="reference"><a href="#cite_note-cvvh-70"><span>[</span>70<span>]</span></a></sup><sup id="cite_ref-hd_71-0" class="reference"><a href="#cite_note-hd-71"><span>[</span>71<span>]</span></a></sup><sup id="cite_ref-72" class="reference"><a href="#cite_note-72"><span>[</span>72<span>]</span></a></sup></p>
<p>Metformin may be quantitated in blood, plasma, or serum to monitor therapy, confirm a diagnosis of poisoning, or assist in a medicolegal death investigation. Blood or plasma metformin concentrations are usually in a range of 1–4&#160;mg/L in persons receiving the drug therapeutically, 40–120&#160;mg/L in victims of acute overdosage, and 80–200&#160;mg/L in fatalities. Chromatographic techniques are commonly employed.<sup id="cite_ref-73" class="reference"><a href="#cite_note-73"><span>[</span>73<span>]</span></a></sup><sup id="cite_ref-74" class="reference"><a href="#cite_note-74"><span>[</span>74<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Interactions">Interactions</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=11" title="Edit section: Interactions">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <a href="/wiki/H2_antagonist" title="H2 antagonist">H<sub>2</sub>-receptor antagonist</a> <a href="/wiki/Cimetidine" title="Cimetidine">cimetidine</a> causes an increase in the plasma concentration of metformin, by reducing <a href="/wiki/Clearance_(medicine)" title="Clearance (medicine)">clearance</a> of metformin by the kidneys;<sup id="cite_ref-75" class="reference"><a href="#cite_note-75"><span>[</span>75<span>]</span></a></sup> both metformin and cimetidine are cleared from the body by <a href="/wiki/Renal_physiology#Secretion" title="Renal physiology">tubular secretion</a>, and both, particularly the <a href="/wiki/Cation" title="Cation" class="mw-redirect">cationic</a> (positively <a href="/wiki/Electric_charge" title="Electric charge">charged</a>) form of cimetidine, may compete for the same transport mechanism.<sup id="cite_ref-PI_76-0" class="reference"><a href="#cite_note-PI-76"><span>[</span>76<span>]</span></a></sup> A small <a href="/wiki/Blind_experiment" title="Blind experiment">double-blind</a>, randomized study found the <a href="/wiki/Antibiotic" title="Antibiotic" class="mw-redirect">antibiotic</a> <a href="/wiki/Cephalexin" title="Cephalexin" class="mw-redirect">cephalexin</a> to also increase metformin concentrations by a similar mechanism;<sup id="cite_ref-77" class="reference"><a href="#cite_note-77"><span>[</span>77<span>]</span></a></sup> theoretically, other cationic medications may produce the same effect.<sup id="cite_ref-PI_76-1" class="reference"><a href="#cite_note-PI-76"><span>[</span>76<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Mechanism_of_action">Mechanism of action</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=12" title="Edit section: Mechanism of action">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Metformin decreases hyperglycemia primarily by suppressing glucose production by the liver (hepatic <a href="/wiki/Gluconeogenesis" title="Gluconeogenesis">gluconeogenesis</a>).<sup id="cite_ref-Kirpichnikov_59-1" class="reference"><a href="#cite_note-Kirpichnikov-59"><span>[</span>59<span>]</span></a></sup> The "average" person with type 2 diabetes has three times the normal rate of gluconeogenesis; metformin treatment reduces this by over one third.<sup id="cite_ref-Hundal_78-0" class="reference"><a href="#cite_note-Hundal-78"><span>[</span>78<span>]</span></a></sup> The molecular mechanism of metformin is incompletely understood: inhibition of the mitochondrial respiratory chain (complex I), activation of <a href="/wiki/AMP-activated_protein_kinase" title="AMP-activated protein kinase">AMP-activated protein kinase</a> (AMPK), inhibition of glucagon-induced elevation of <a href="/wiki/Cyclic_adenosine_monophosphate" title="Cyclic adenosine monophosphate">cyclic adenosine monophosphate</a> (cAMP) and consequent activation of <a href="/wiki/Protein_kinase_A" title="Protein kinase A">protein kinase A</a> (PKA), and an effect on <a href="/wiki/Gut_flora" title="Gut flora">gut microbiota</a> have been proposed as potential mechanisms.<sup id="cite_ref-Rena_2013_79-0" class="reference"><a href="#cite_note-Rena_2013-79"><span>[</span>79<span>]</span></a></sup><sup id="cite_ref-Burcelin_80-0" class="reference"><a href="#cite_note-Burcelin-80"><span>[</span>80<span>]</span></a></sup> A study in 2001 suggested that activation of AMPK, an enzyme that plays an important role in insulin signaling, whole body energy balance, and the metabolism of glucose and <a href="/wiki/Lipid" title="Lipid">fats</a>,<sup id="cite_ref-81" class="reference"><a href="#cite_note-81"><span>[</span>81<span>]</span></a></sup> was required for metformin's inhibitory effect on the production of glucose by liver cells.<sup id="cite_ref-Zhou_82-0" class="reference"><a href="#cite_note-Zhou-82"><span>[</span>82<span>]</span></a></sup> Research published in 2008 further showed that activation of AMPK was required for an increase in the expression of <a href="/wiki/Small_heterodimer_partner" title="Small heterodimer partner">SHP</a>, which in turn inhibited the <a href="/wiki/Gene_expression" title="Gene expression">expression</a> of the hepatic gluconeogenic genes <a href="/wiki/Phosphoenolpyruvate_carboxykinase" title="Phosphoenolpyruvate carboxykinase">PEPCK</a> and <a href="/wiki/Glucose_6-phosphatase" title="Glucose 6-phosphatase">Glc-6-Pase</a>.<sup id="cite_ref-83" class="reference"><a href="#cite_note-83"><span>[</span>83<span>]</span></a></sup> Metformin is frequently used in research along with <a href="/wiki/AICA_ribonucleotide" title="AICA ribonucleotide">AICAR</a> as an AMPK agonist. More recent studies using mouse models in which the genes for AMPKα1 and α2 catalytic subunits (Prkaa1/2) or <a href="/wiki/STK11" title="STK11">LKB1</a>, an upstream kinase of AMPK, had been knocked out in hepatocytes have raised doubts over the obligatory role of AMPK, since the effect of metformin was not abolished by loss of AMPK function.<sup id="cite_ref-Rena_2013_79-1" class="reference"><a href="#cite_note-Rena_2013-79"><span>[</span>79<span>]</span></a></sup> The mechanism by which biguanides increase the activity of AMPK remains uncertain; however, research suggests that metformin increases the concentration of <a href="/wiki/Cytosol" title="Cytosol">cytosolic</a> <a href="/wiki/Adenosine_monophosphate" title="Adenosine monophosphate">AMP</a> (as opposed to a change in total AMP or total AMP/<a href="/wiki/Adenosine_triphosphate" title="Adenosine triphosphate">ATP</a>).<sup id="cite_ref-84" class="reference"><a href="#cite_note-84"><span>[</span>84<span>]</span></a></sup> Increased cellular AMP has also been proposed to explain the inhibition of glucagon-induced increase in cAMP and activation of PKA.<sup id="cite_ref-Rena_2013_79-2" class="reference"><a href="#cite_note-Rena_2013-79"><span>[</span>79<span>]</span></a></sup> Metformin and other biguanides may antagonize the action of <a href="/wiki/Glucagon" title="Glucagon">glucagon</a>, thus reducing fasting glucose levels.<sup id="cite_ref-Miller2013_85-0" class="reference"><a href="#cite_note-Miller2013-85"><span>[</span>85<span>]</span></a></sup> Metformin also induces a profound shift in the faecal microbial community profile in diabetic mice and it has also been proposed that this may contribute to its mode of action possibly through an effect on <a href="/wiki/Glucagon-like_peptide-1" title="Glucagon-like peptide-1">Glucagon-like peptide-1</a> (GLP-1) secretion.<sup id="cite_ref-Burcelin_80-1" class="reference"><a href="#cite_note-Burcelin-80"><span>[</span>80<span>]</span></a></sup></p>
<p>In addition to suppressing hepatic glucose production, metformin increases insulin sensitivity, enhances peripheral <a href="/wiki/Glucose_uptake" title="Glucose uptake">glucose uptake</a> (by inducing the phosphorylation of GLUT4 enhancer factor), decreases insulin-induced suppression of <a href="/wiki/Fatty_acid_metabolism" title="Fatty acid metabolism">fatty acid oxidation</a>,<sup id="cite_ref-86" class="reference"><a href="#cite_note-86"><span>[</span>86<span>]</span></a></sup> and decreases absorption of glucose from the <a href="/wiki/Gastrointestinal_tract" title="Gastrointestinal tract" class="mw-redirect">gastrointestinal tract</a>. Increased peripheral utilization of glucose may be due to improved insulin binding to insulin receptors.<sup id="cite_ref-87" class="reference"><a href="#cite_note-87"><span>[</span>87<span>]</span></a></sup> The increase in insulin binding after metformin treatment has also been demonstrated in patients with NIDDM <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pubmed/3745404"><sup id="cite_ref-88" class="reference"></sup></a><a href="#cite_note-88"><span>[</span>88<span>]</span></a>. AMPK probably also plays a role, as metformin administration increases AMPK activity in skeletal muscle.<sup id="cite_ref-89" class="reference"><a href="#cite_note-89"><span>[</span>89<span>]</span></a></sup> AMPK is known to cause <a href="/wiki/GLUT4" title="GLUT4">GLUT4</a> deployment to the plasma membrane, resulting in insulin-independent glucose uptake. Some metabolic actions of metformin do appear to occur by AMPK-independent mechanisms; a 2008 study found "the metabolic actions of metformin in the heart muscle can occur independent of changes in AMPK activity and may be mediated by <a href="/wiki/P38_mitogen-activated_protein_kinases" title="P38 mitogen-activated protein kinases">p38 MAPK</a>- and <a href="/wiki/Protein_kinase_C" title="Protein kinase C">PKC</a>-dependent mechanisms."<sup id="cite_ref-90" class="reference"><a href="#cite_note-90"><span>[</span>90<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Chemistry">Chemistry</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=13" title="Edit section: Chemistry">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The usual <a href="/wiki/Chemical_synthesis" title="Chemical synthesis">synthesis</a> of metformin, originally described in 1922 and reproduced in multiple later patents and publications, involves the reaction of <a href="/wiki/Dimethylamine" title="Dimethylamine">dimethylamine</a> <a href="/wiki/Hydrochloride" title="Hydrochloride">hydrochloride</a> and <a href="/wiki/2-cyanoguanidine" title="2-cyanoguanidine" class="mw-redirect">2-cyanoguanidine</a> (dicyandiamide) with heating.<sup id="cite_ref-werner_91-0" class="reference"><a href="#cite_note-werner-91"><span>[</span>91<span>]</span></a></sup><sup id="cite_ref-92" class="reference"><a href="#cite_note-92"><span>[</span>92<span>]</span></a></sup></p>
<div class="center">
<div class="floatnone"><a href="/wiki/File:Metformin_synthesis.svg" class="image"><img alt="Metformin synthesis.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/62/Metformin_synthesis.svg/300px-Metformin_synthesis.svg.png" width="300" height="96" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/62/Metformin_synthesis.svg/450px-Metformin_synthesis.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/62/Metformin_synthesis.svg/600px-Metformin_synthesis.svg.png 2x" /></a></div>
</div>
<p>According to the procedure described in the 1975 Aron patent,<sup id="cite_ref-93" class="reference"><a href="#cite_note-93"><span>[</span>93<span>]</span></a></sup> and the <i>Pharmaceutical Manufacturing Encyclopedia</i>,<sup id="cite_ref-isbn0-8155-1526-X_94-0" class="reference"><a href="#cite_note-isbn0-8155-1526-X-94"><span>[</span>94<span>]</span></a></sup> <a href="/wiki/Equivalent_weight" title="Equivalent weight">equimolar</a> amounts of dimethylamine and 2-cyanoguanidine are dissolved in <a href="/wiki/Toluene" title="Toluene">toluene</a> with cooling to make a <a href="/wiki/Concentration#Qualitative_description" title="Concentration">concentrated</a> solution, and an equimolar amount of <a href="/wiki/Hydrogen_chloride" title="Hydrogen chloride">hydrogen chloride</a> is slowly added. The mixture begins to boil on its own, and after cooling, metformin hydrochloride <a href="/wiki/Precipitate" title="Precipitate" class="mw-redirect">precipitates</a> with a 96% <a href="/wiki/Yield_(chemistry)" title="Yield (chemistry)">yield</a>.</p>
<h2><span class="mw-headline" id="Structure">Structure</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=14" title="Edit section: Structure">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The structure of metformin was generally represented in a wrong tautomeric form for a number of years. This was corrected in 2005.<sup id="cite_ref-95" class="reference"><a href="#cite_note-95"><span>[</span>95<span>]</span></a></sup> The energy difference between the correct tautomer and the generally represented tautomer is about 37 kJ/mol (9 kcal/mol). The drug is administered as metformin hydrochloride. The structure of the metformin hydrochloride was also corrected recently.<sup id="cite_ref-96" class="reference"><a href="#cite_note-96"><span>[</span>96<span>]</span></a></sup> According to these studies, the metformin has different electronic structure compared to its protonated form. The neutral species is a simple conjugated system. Upon protonation, (i) the conjugation breaks down, (ii) the intramolecular hydrogen bond breaks down, (iii) the molecule becomes non-planar (iv) two lone pairs get accumulated at the central nitrogen (v) dynamism increases in the system via C=N rotational process and via N-inversion process. Thus, electronically, metformin hydrochloride should be treated as a simple extension of metformin. The nucleophilicity of metformin hydrochloride is moderate and that is a desired property. Metformin is shown to belong to a new class of compounds called nitreones.</p>
<h2><span class="mw-headline" id="Pharmacokinetics">Pharmacokinetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=15" title="Edit section: Pharmacokinetics">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Metformin has an oral <a href="/wiki/Bioavailability" title="Bioavailability">bioavailability</a> of 50–60% under <a href="/wiki/Fasting" title="Fasting">fasting</a> conditions, and is absorbed slowly.<sup id="cite_ref-PI_76-2" class="reference"><a href="#cite_note-PI-76"><span>[</span>76<span>]</span></a></sup><sup id="cite_ref-Heller_97-0" class="reference"><a href="#cite_note-Heller-97"><span>[</span>97<span>]</span></a></sup> Peak plasma concentrations (C<sub>max</sub>) are reached within one to three hours of taking immediate-release metformin and four to eight hours with extended-release formulations.<sup id="cite_ref-PI_76-3" class="reference"><a href="#cite_note-PI-76"><span>[</span>76<span>]</span></a></sup><sup id="cite_ref-Heller_97-1" class="reference"><a href="#cite_note-Heller-97"><span>[</span>97<span>]</span></a></sup> The <a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">plasma protein binding</a> of metformin is negligible, as reflected by its very high <a href="/wiki/Volume_of_distribution" title="Volume of distribution">apparent volume of distribution</a> (300–1000&#160;L after a single dose). <a href="/wiki/Steady_state" title="Steady state">Steady state</a> is usually reached in one or two days.<sup id="cite_ref-PI_76-4" class="reference"><a href="#cite_note-PI-76"><span>[</span>76<span>]</span></a></sup></p>
<p>Metformin has acid dissociation constant values (pKa) of 2.8 and 11.5 and, therefore, exists very largely as the hydrophilic cationic species at physiological pH values. The metformin acid dissociation constant values (pKa) make metformin a stronger base than most other basic drugs with less than 0.01% unionized in blood. Furthermore, the lipid solubility of the unionized species is slight as shown by its low logP value [log(10) of the distribution coefficient of the unionized form between octanol and water] of -1.43. These chemical parameters indicate low lipophilicity and, consequently, rapid passive diffusion of metformin through cell membranes is unlikely. The logP of metformin is less than that of <a href="/wiki/Phenformin" title="Phenformin">phenformin</a> (-0.84) because two methyl substituents on metformin impart lesser lipophilicity than the larger phenylethyl side chain in phenformin. More lipophilic derivatives of metformin are presently being investigated with the aim of producing prodrugs with better oral absorption than metformin itself.<sup id="cite_ref-98" class="reference"><a href="#cite_note-98"><span>[</span>98<span>]</span></a></sup></p>
<p>Metformin is not <a href="/wiki/Drug_metabolism" title="Drug metabolism">metabolized</a>. It is <a href="/wiki/Clearance_(medicine)" title="Clearance (medicine)">cleared</a> from the body by <a href="/wiki/Renal_physiology#Secretion" title="Renal physiology">tubular secretion</a> and excreted unchanged in the urine; metformin is undetectable in <a href="/wiki/Blood_plasma" title="Blood plasma">blood plasma</a> within 24 hours of a single oral dose.<sup id="cite_ref-PI_76-5" class="reference"><a href="#cite_note-PI-76"><span>[</span>76<span>]</span></a></sup><sup id="cite_ref-Robert_99-0" class="reference"><a href="#cite_note-Robert-99"><span>[</span>99<span>]</span></a></sup> The average <a href="/wiki/Biological_half-life" title="Biological half-life">elimination half-life</a> in plasma is 6.2 hours.<sup id="cite_ref-PI_76-6" class="reference"><a href="#cite_note-PI-76"><span>[</span>76<span>]</span></a></sup> Metformin is distributed to (and appears to accumulate in) <a href="/wiki/Red_blood_cell" title="Red blood cell">red blood cells</a>, with a much longer elimination half-life: 17.6 hours<sup id="cite_ref-PI_76-7" class="reference"><a href="#cite_note-PI-76"><span>[</span>76<span>]</span></a></sup> (reported as ranging from 18.5 to 31.5 hours in a single-dose study of non-diabetic people).<sup id="cite_ref-Robert_99-1" class="reference"><a href="#cite_note-Robert-99"><span>[</span>99<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=16" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The <a href="/wiki/Biguanide" title="Biguanide">biguanide</a> class of antidiabetic drugs, which also includes the withdrawn agents <a href="/wiki/Phenformin" title="Phenformin">phenformin</a> and <a href="/wiki/Buformin" title="Buformin">buformin</a>, originates from the <a href="/wiki/Galega_officinalis" title="Galega officinalis">French lilac</a> or goat's rue (<i>Galega officinalis</i>), a plant used in folk medicine for several centuries.<sup id="cite_ref-Witters_100-0" class="reference"><a href="#cite_note-Witters-100"><span>[</span>100<span>]</span></a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Galega_officinalis1UME.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/06/Galega_officinalis1UME.jpg/220px-Galega_officinalis1UME.jpg" width="220" height="293" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/06/Galega_officinalis1UME.jpg/330px-Galega_officinalis1UME.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/06/Galega_officinalis1UME.jpg/440px-Galega_officinalis1UME.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Galega_officinalis1UME.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
<i>Galega officinalis</i>, a natural source of galegine</div>
</div>
</div>
<p>Metformin was first described in the scientific literature in 1922, by Emil Werner and James Bell, as a product in the synthesis of <i>N</i>,<i>N</i>-dimethylguanidine.<sup id="cite_ref-werner_91-1" class="reference"><a href="#cite_note-werner-91"><span>[</span>91<span>]</span></a></sup> In 1929, Slotta and Tschesche discovered its sugar-lowering action in rabbits, noting it was the most potent of the biguanide analogs they studied.<sup id="cite_ref-slotta_101-0" class="reference"><a href="#cite_note-slotta-101"><span>[</span>101<span>]</span></a></sup> This result was completely forgotten, as other <a href="/wiki/Guanidine" title="Guanidine">guanidine</a> analogs, such as the <a href="/wiki/Synthalin" title="Synthalin">synthalins</a>, took over, and were themselves soon overshadowed by insulin.<sup id="cite_ref-fifty_102-0" class="reference"><a href="#cite_note-fifty-102"><span>[</span>102<span>]</span></a></sup></p>
<p>Interest in metformin, however, picked up at the end of the 1940s. In 1950, metformin, unlike some other similar compounds, was found not to decrease blood pressure and heart rate in animals.<sup id="cite_ref-pmid15405470_103-0" class="reference"><a href="#cite_note-pmid15405470-103"><span>[</span>103<span>]</span></a></sup> That same year, a prominent Philippine physician, Eusebio Y. Garcia,<sup id="cite_ref-104" class="reference"><a href="#cite_note-104"><span>[</span>104<span>]</span></a></sup> used metformin (he named it <i>Fluamine</i>) to treat influenza; he noted the drug "lowered the blood sugar to minimum physiological limit" and was nontoxic. Garcia also believed metformin to have <a href="/wiki/Bacteriostatic" title="Bacteriostatic" class="mw-redirect">bacteriostatic</a>, <a href="/wiki/Antiviral_drug" title="Antiviral drug">antiviral</a>, <a href="/wiki/Antimalarial" title="Antimalarial" class="mw-redirect">antimalarial</a>, <a href="/wiki/Antipyretic" title="Antipyretic">antipyretic</a> and <a href="/wiki/Analgesic" title="Analgesic">analgesic</a> actions.<sup id="cite_ref-Garcia_105-0" class="reference"><a href="#cite_note-Garcia-105"><span>[</span>105<span>]</span></a></sup> In a series of articles in 1954, Polish pharmacologist Janusz Supniewski<sup id="cite_ref-pmid16766803_106-0" class="reference"><a href="#cite_note-pmid16766803-106"><span>[</span>106<span>]</span></a></sup> was unable to confirm most of these effects, including lowered blood sugar; he did, however, observe some antiviral effects in humans.<sup id="cite_ref-pmid13269290_107-0" class="reference"><a href="#cite_note-pmid13269290-107"><span>[</span>107<span>]</span></a></sup><sup id="cite_ref-supniewski2_108-0" class="reference"><a href="#cite_note-supniewski2-108"><span>[</span>108<span>]</span></a></sup></p>
<p>While training at the <a href="/wiki/Piti%C3%A9-Salp%C3%AAtri%C3%A8re_Hospital" title="Pitié-Salpêtrière Hospital">Hôpital de la Pitié</a>, French diabetologist Jean Sterne studied the antihyperglycemic properties of galegine, an <a href="/wiki/Alkaloid" title="Alkaloid">alkaloid</a> isolated from <i>Galega officinalis</i>, which is related in structure to metformin and had seen brief use as an antidiabetic before the synthalins were developed.<sup id="cite_ref-Bailey_8-1" class="reference"><a href="#cite_note-Bailey-8"><span>[</span>8<span>]</span></a></sup> Later, working at Laboratoires Aron in Paris, he was prompted by Garcia's report to reinvestigate the blood sugar lowering activity of metformin and several biguanide analogs. Sterne was the first to try metformin on humans for the treatment of diabetes; he coined the name "Glucophage" (glucose eater) for the drug and published his results in 1957.<sup id="cite_ref-Bailey_8-2" class="reference"><a href="#cite_note-Bailey-8"><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-fifty_102-1" class="reference"><a href="#cite_note-fifty-102"><span>[</span>102<span>]</span></a></sup></p>
<p>Metformin became available in the <a href="/wiki/British_National_Formulary" title="British National Formulary">British National Formulary</a> in 1958. It was sold in the UK by a small Aron subsidiary called Rona. <sup id="cite_ref-pmid16402501_109-0" class="reference"><a href="#cite_note-pmid16402501-109"><span>[</span>109<span>]</span></a></sup></p>
<p>Broad interest in metformin was not rekindled until the withdrawal of the other biguanides in the 1970s. Metformin was approved in Canada in 1972,<sup id="cite_ref-110" class="reference"><a href="#cite_note-110"><span>[</span>110<span>]</span></a></sup> but did not receive approval by the U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) for type 2 diabetes until 1994.<sup id="cite_ref-FDAapproval_111-0" class="reference"><a href="#cite_note-FDAapproval-111"><span>[</span>111<span>]</span></a></sup> Produced under license by <a href="/wiki/Bristol-Myers_Squibb" title="Bristol-Myers Squibb">Bristol-Myers Squibb</a>, Glucophage was the first branded formulation of metformin to be marketed in the United States, beginning on March 3, 1995.<sup id="cite_ref-112" class="reference"><a href="#cite_note-112"><span>[</span>112<span>]</span></a></sup> <a href="/wiki/Generic_drug" title="Generic drug">Generic</a> formulations are now available in several countries, and metformin is believed to have become the most widely prescribed antidiabetic drug in the world.<sup id="cite_ref-Bailey_8-3" class="reference"><a href="#cite_note-Bailey-8"><span>[</span>8<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Formulations">Formulations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=17" title="Edit section: Formulations">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Metformin_500mg_Tablets.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/db/Metformin_500mg_Tablets.jpg/220px-Metformin_500mg_Tablets.jpg" width="220" height="194" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/db/Metformin_500mg_Tablets.jpg/330px-Metformin_500mg_Tablets.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/db/Metformin_500mg_Tablets.jpg/440px-Metformin_500mg_Tablets.jpg 2x" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Metformin_500mg_Tablets.jpg" class="internal" title="Enlarge"><img src="//bits.wikimedia.org/static-1.23wmf18/skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Generic metformin 500&#160;mg tablets, as sold in the United Kingdom</div>
</div>
</div>
<p>Metformin is sold under several <a href="/wiki/Trade_name" title="Trade name">trade names</a>, including Glucophage XR, Carbophage SR, Riomet, Fortamet, Glumetza, Obimet, Gluformin, Dianben, Diabex, Diaformin, Siofor and Metfogamma.</p>
<p>The liquid metformin is sold under the name Riomet. Each 5&#160;ml of Riomet is equivalent to the 500&#160;mg tablet form of metformin.<sup id="cite_ref-113" class="reference"><a href="#cite_note-113"><span>[</span>113<span>]</span></a></sup></p>
<p>Metformin IR (immediate release) is available in 500&#160;mg, 850&#160;mg, and 1000&#160;mg tablets. All of these are now available as generic drugs in the U.S.</p>
<p>Metformin SR (slow release) or XR (extended release) was introduced in 2004. It is available in 500&#160;mg, 750&#160;mg and 1000&#160;mg strengths, mainly to counteract the most common gastrointestinal side effects, as well as to increase compliance by reducing <a href="/wiki/Pill_burden" title="Pill burden" class="mw-redirect">pill burden</a>. No difference in effectiveness exists between the two preparations.</p>
<h3><span class="mw-headline" id="Combinations_with_other_drugs">Combinations with other drugs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=18" title="Edit section: Combinations with other drugs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>When used for type 2 diabetes, metformin is often prescribed in combination with other drugs. Several are available as <a href="/wiki/Fixed-dose_combination" title="Fixed-dose combination" class="mw-redirect">fixed-dose combinations</a>, also with the purpose of reducing pill burden and making administration simpler and more convenient.<sup id="cite_ref-FDC_114-0" class="reference"><a href="#cite_note-FDC-114"><span>[</span>114<span>]</span></a></sup></p>
<p>As of 2009, the most popular brand-name combination was metformin with <a href="/wiki/Rosiglitazone" title="Rosiglitazone">rosiglitazone</a>, sold as Avandamet by <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a> since 2002.<sup id="cite_ref-115" class="reference"><a href="#cite_note-115"><span>[</span>115<span>]</span></a></sup><sup id="cite_ref-116" class="reference"><a href="#cite_note-116"><span>[</span>116<span>]</span></a></sup> Rosiglitazone actively makes cells more sensitive to insulin, complementing the action of the metformin. In 2005, all current stock of Avandamet was seized by the FDA and removed from the market, after inspections showed the factory where it was produced was violating <a href="/wiki/Good_manufacturing_practice" title="Good manufacturing practice">good manufacturing practices</a>.<sup id="cite_ref-117" class="reference"><a href="#cite_note-117"><span>[</span>117<span>]</span></a></sup> The drug pair continued to be prescribed separately in the absence of Avandamet, which was available again by the end of that year.</p>
<p>In the United States, metformin is also available in combination with <a href="/wiki/Pioglitazone" title="Pioglitazone">pioglitazone</a> (trade name Actoplus Met), the sulfonylureas <a href="/wiki/Glipizide" title="Glipizide">glipizide</a> (trade name Metaglip) and <a href="/wiki/Glibenclamide" title="Glibenclamide">glibenclamide</a> (known as glyburide in the United States, trade name Glucovance), the <a href="/wiki/Dipeptidyl_peptidase-4_inhibitors" title="Dipeptidyl peptidase-4 inhibitors" class="mw-redirect">dipeptidyl peptidase-4 inhibitor</a> <a href="/wiki/Sitagliptin" title="Sitagliptin">sitagliptin</a> (with the combination sold under the trade name <a href="/wiki/Janumet" title="Janumet" class="mw-redirect">Janumet</a>), the <a href="/wiki/Dipeptidyl_peptidase-4_inhibitors" title="Dipeptidyl peptidase-4 inhibitors" class="mw-redirect">dipeptidyl peptidase-4 inhibitor</a> <a href="/wiki/Saxagliptin" title="Saxagliptin">saxagliptin</a> (with the combination sold under the trade name <a href="/w/index.php?title=Kombiglyze_XR&amp;action=edit&amp;redlink=1" class="new" title="Kombiglyze XR (page does not exist)">Kombiglyze XR</a>), and the <a href="/wiki/Meglitinide" title="Meglitinide">meglitinide</a> <a href="/wiki/Repaglinide" title="Repaglinide">repaglinide</a> (PrandiMet). Generic formulations of metformin/glipizide and metformin/glibenclamide are available (the latter being more popular).<sup id="cite_ref-Top200Generics_9-1" class="reference"><a href="#cite_note-Top200Generics-9"><span>[</span>9<span>]</span></a></sup> A generic formulation of metformin/rosiglitazone from <a href="/wiki/Teva_Pharmaceutical_Industries" title="Teva Pharmaceutical Industries">Teva</a> has received tentative approval from the FDA, and is expected to reach the market in early 2012.<sup id="cite_ref-118" class="reference"><a href="#cite_note-118"><span>[</span>118<span>]</span></a></sup></p>
<p><span id="Jentadueto"></span> In <a href="/wiki/Europe" title="Europe">Europe</a>, the combination of metformin and the <a href="/wiki/Dipeptidyl_peptidase-4_inhibitor" title="Dipeptidyl peptidase-4 inhibitor">dipeptidyl peptidase-4 inhibitor</a> <a href="/wiki/Linagliptin" title="Linagliptin">linagliptin</a> has approved the trade name <i>Jentadueto</i>.<sup id="cite_ref-119" class="reference"><a href="#cite_note-119"><span>[</span>119<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=19" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There is tentative evidence that metformin may decrease the risk of cancer.<sup id="cite_ref-120" class="reference"><a href="#cite_note-120"><span>[</span>120<span>]</span></a></sup></p>
<p>A direct action of metformin on cancer cells is suspected. Metformin exhibits a strong and consistent antiproliferative action on several cancer cell lines, including breast, colon, ovarian, pancreatic, lung and prostate cancer cells. These cellular studies were generally completed by preclinical studies showing a reliable antitumoral effect in various mouse models. In addition, the first clinical trials demonstrated a beneficial effect in breast and colon cancer.<sup id="cite_ref-pmid20442309_121-0" class="reference"><a href="#cite_note-pmid20442309-121"><span>[</span>121<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=20" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-D95-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-D95_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-D95_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-D95_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-D95_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-D95_1-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Dunn CJ, Peters DH (May 1995). "Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus". <i>Drugs</i> <b>49</b> (5): 721–49. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2165%2F00003495-199549050-00007">10.2165/00003495-199549050-00007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7601013">7601013</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetformin&amp;rft.atitle=Metformin.+A+review+of+its+pharmacological+properties+and+therapeutic+use+in+non-insulin-dependent+diabetes+mellitus&amp;rft.au=Dunn+CJ%2C+Peters+DH&amp;rft.aulast=Dunn+CJ%2C+Peters+DH&amp;rft.date=May+1995&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F00003495-199549050-00007&amp;rft_id=info%3Apmid%2F7601013&amp;rft.issue=5&amp;rft.jtitle=Drugs&amp;rft.pages=721%E2%80%9349&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=49" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-D03-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-D03_2-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hundal RS, Inzucchi SE (2003). "Metformin: new understandings, new uses". <i>Drugs</i> <b>63</b> (18): 1879–94. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2165%2F00003495-200363180-00001">10.2165/00003495-200363180-00001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12930161">12930161</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetformin&amp;rft.atitle=Metformin%3A+new+understandings%2C+new+uses&amp;rft.au=Hundal+RS%2C+Inzucchi+SE&amp;rft.aulast=Hundal+RS%2C+Inzucchi+SE&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F00003495-200363180-00001&amp;rft_id=info%3Apmid%2F12930161&amp;rft.issue=18&amp;rft.jtitle=Drugs&amp;rft.pages=1879%E2%80%9394&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=63" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text">Clinical Guidelines Task Force, <a href="/wiki/International_Diabetes_Federation" title="International Diabetes Federation">International Diabetes Federation</a> (2005). <span class="PDFlink"><a rel="nofollow" class="external text" href="http://www.idf.org/webdata/docs/GGT2D%2009%20Oral%20therapy.pdf">"Glucose control: oral therapy"</a></span><span style="font-size:smaller;">&#160;PDF&#160;(100&#160;KB)</span>. In: <i><a rel="nofollow" class="external text" href="http://www.idf.org/Global_guideline">Global Guideline for Type 2 Diabetes</a></i>. Brussels: International Diabetes Federation, 35–8. Retrieved November 6, 2007.</span></li>
<li id="cite_note-NICErecommendations-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-NICErecommendations_4-0">^</a></b></span> <span class="reference-text"><span class="citation">National Collaborating Centre for Chronic Conditions. <i><a rel="nofollow" class="external text" href="http://www.nice.org.uk/nicemedia/pdf/CG66FullGuideline0509.pdf">Type 2 diabetes: national clinical guideline for management in primary and secondary care (update)</a></i> [pdf]. London: Royal College of Physicians; 2008. <a href="/wiki/Special:BookSources/9781860163333" class="internal mw-magiclink-isbn">ISBN 978-1-86016-333-3</a>. p. 86.</span></span></li>
<li id="cite_note-ADAstandardsOfCare-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-ADAstandardsOfCare_5-0">^</a></b></span> <span class="reference-text"><span class="citation"><a href="/wiki/American_Diabetes_Association" title="American Diabetes Association">American Diabetes Association</a>.  <a rel="nofollow" class="external text" href="http://care.diabetesjournals.org/content/32/Supplement_1/S13.full">Standards of medical care in diabetes—2009</a>. <i>Diabetes Care</i>. 2009;32 Suppl 1:S13–61. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2337%2Fdc09-S013">10.2337/dc09-S013</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19118286?dopt=Abstract">PMID 19118286</a>.</span></span></li>
<li id="cite_note-WHOessential-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-WHOessential_6-0">^</a></b></span> <span class="reference-text">(March 2010) <span class="PDFlink"><a rel="nofollow" class="external text" href="http://www.who.int/entity/medicines/publications/essentialmedicines/Updated_sixteenth_adult_list_en.pdf"><i>WHO Model List of Essential Medicines</i></a></span><span style="font-size:smaller;">&#160;PDF&#160;(433&#160;KB)</span>, 16th edition, <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a>, p. 24. Retrieved December 22, 2010.</span></li>
<li id="cite_note-pmid21617112-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21617112_7-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lipska KJ, Bailey CJ, Inzucchi SE (June 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3114336">"Use of metformin in the setting of mild-to-moderate renal insufficiency"</a>. <i>Diabetes Care</i> <b>34</b> (6): 1431–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2337%2Fdc10-2361">10.2337/dc10-2361</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3114336">3114336</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21617112">21617112</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetformin&amp;rft.atitle=Use+of+metformin+in+the+setting+of+mild-to-moderate+renal+insufficiency&amp;rft.aulast=Lipska+KJ%2C+Bailey+CJ%2C+Inzucchi+SE&amp;rft.au=Lipska+KJ%2C+Bailey+CJ%2C+Inzucchi+SE&amp;rft.date=June+2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3114336&amp;rft_id=info%3Adoi%2F10.2337%2Fdc10-2361&amp;rft_id=info%3Apmc%2F3114336&amp;rft_id=info%3Apmid%2F21617112&amp;rft.issue=6&amp;rft.jtitle=Diabetes+Care&amp;rft.pages=1431%E2%80%937&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Bailey-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Bailey_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bailey_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Bailey_8-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Bailey_8-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation">Bailey CJ, Day C.  <a rel="nofollow" class="external text" href="http://www3.interscience.wiley.com/cgi-bin/fulltext/108564133/HTMLSTART">Metformin: its botanical background</a>. <i>Practical Diabetes International</i>. 2004;21(3):115–7. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fpdi.606">10.1002/pdi.606</a>.</span></span></li>
<li id="cite_note-Top200Generics-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Top200Generics_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Top200Generics_9-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="PDFlink"><a rel="nofollow" class="external text" href="http://www.imshealth.com/deployedfiles/imshealth/Global/Content/IMS%20Institute/Static%20File/IHII_UseOfMed_report.pdf">"The Use of Medicines in the United States: Review of 2010"</a></span><span style="font-size:smaller;">&#160;PDF&#160;(1.79&#160;MB)</span>. IMS Institute for Healthcare Informatics (April 2011). Retrieved April 28, 2011.</span></li>
<li id="cite_note-Lord-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-Lord_10-0">^</a></b></span> <span class="reference-text"><span class="citation">Lord JM, Flight IHK, Norman RJ.  <a rel="nofollow" class="external text" href="http://www.bmj.com/cgi/content/full/327/7421/951">Metformin in polycystic ovary syndrome: systematic review and meta-analysis</a>. <i>BMJ</i>. 2003;327(7421):951–3. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fbmj.327.7421.951">10.1136/bmj.327.7421.951</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/14576245?dopt=Abstract">PMID 14576245</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC259161/">259161</a>.</span></span></li>
<li id="cite_note-Marchesini-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-Marchesini_11-0">^</a></b></span> <span class="reference-text"><span class="citation">Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Melchionda N.  Metformin in non-alcoholic steatohepatitis. <i><a href="/wiki/The_Lancet" title="The Lancet">Lancet</a></i>. 2001;358(9285):893–4. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0140-6736%2801%2906042-1">10.1016/S0140-6736(01)06042-1</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/11567710?dopt=Abstract">PMID 11567710</a>.</span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation">Ibáñez L, Ong K, Valls C, Marcos MV, Dunger DB, de Zegher F.  Metformin treatment to prevent early puberty in girls with precocious pubarche. <i>J Clin Endocrinol Metab</i>. 2006;91(8):2888–91. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1210%2Fjc.2006-0336">10.1210/jc.2006-0336</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/16684823?dopt=Abstract">PMID 16684823</a>.</span></span></li>
<li id="cite_note-Nair-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nair_13-0">^</a></b></span> <span class="reference-text"><span class="citation">Nair S, Diehl AM, Wiseman M, Farr GH Jr, Perrillo RP.  Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. <i>Aliment Pharmacol Ther</i>. 2004;20(1):23–28. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1365-2036.2004.02025.x">10.1111/j.1365-2036.2004.02025.x</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/15225167?dopt=Abstract">PMID 15225167</a>.</span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation">Angelico F, Burattin M, Alessandri C, Del Ben M, Lirussi F.  <a rel="nofollow" class="external text" href="http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005166/frame.html">Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis</a>. <i>Cochrane Database Syst Rev</i>. 2007;24(1):CD005166. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD005166.pub2">10.1002/14651858.CD005166.pub2</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/17253544?dopt=Abstract">PMID 17253544</a>.</span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation">Socha P, Horvath A, Vajro P, Dziechciarz P, Dhawan A, Szajewska H.  Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review. <i>J Pediatr Gastroenterol Nutr</i>. 2009;48(5):587–96. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19412008?dopt=Abstract">PMID 19412008</a>.</span></span></li>
<li id="cite_note-UKPDS-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-UKPDS_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-UKPDS_16-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation">Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. <i>Lancet</i>. 1998;352(9131):854–65. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0140-6736%2898%2907037-8">10.1016/S0140-6736(98)07037-8</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/9742977?dopt=Abstract">PMID 9742977</a>.</span></span></li>
<li id="cite_note-pmid18784090-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18784090_17-0">^</a></b></span> <span class="reference-text"><span class="citation">Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA.  <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/content/full/359/15/1577">10-year follow-up of intensive glucose control in type 2 diabetes</a>. <i>N Engl J Med</i>. 2008;359(15):1577–89. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJMoa0806470">10.1056/NEJMoa0806470</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/18784090?dopt=Abstract">PMID 18784090</a>.</span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation">Selvin E, Bolen S, Yeh HC, <i>et al.</i>  <a rel="nofollow" class="external text" href="http://archinte.ama-assn.org/cgi/content/full/168/19/2070">Cardiovascular outcomes in trials of oral diabetes medications: a systematic review</a>. <i>Arch Intern Med</i>. 2008;168(19):2070–80. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Farchinte.168.19.2070">10.1001/archinte.168.19.2070</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/18955635?dopt=Abstract">PMID 18955635</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765722/">2765722</a>.</span></span></li>
<li id="cite_note-Umesh-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-Umesh_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Umesh_19-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Umesh_19-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Umesh_19-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation">Maharani U. Chapter 27: Diabetes Mellitus &amp; Hypoglycemia. In: Papadakis MA, McPhee SJ. <i>CURRENT Medical Diagnosis and Treatment 2010</i>. 49th ed. McGraw-Hill Medical; 2009. <a href="/wiki/Special:BookSources/0071624449" class="internal mw-magiclink-isbn">ISBN 0-07-162444-9</a>. p. 1092–93.</span></span></li>
<li id="cite_note-Bolen-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-Bolen_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bolen_20-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Bolen_20-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation">Bolen S, Feldman L, Vassy J, <i>et al.</i>  <a rel="nofollow" class="external text" href="http://www.annals.org/content/147/6/386.long">Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus</a>. <i>Ann Intern Med</i>. 2007;147(6):386–99. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/17638715?dopt=Abstract">PMID 17638715</a>.</span></span></li>
<li id="cite_note-isbn0071416137-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-isbn0071416137_21-0">^</a></b></span> <span class="reference-text"><span class="citation">DiPiro, Joseph T.; Talbert, Robert L.; Yee, Gary C.; Matzke, Gary R.; Wells, Barbara G.; Posey, L. Michael. <i>Pharmacotherapy: a pathophysiologic approach</i>. New York: McGraw-Hill; 2005. <a href="/wiki/Special:BookSources/0071416137" class="internal mw-magiclink-isbn">ISBN 0-07-141613-7</a>.</span></span></li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=18054">"Glucophage package insert"</a>. Princeton, NJ: Bristol-Myers Squibb Company; 2009.</span></li>
<li id="cite_note-DPP-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-DPP_23-0">^</a></b></span> <span class="reference-text"><span class="citation">Knowler WC, Barrett-Connor E, Fowler SE, <i>et al.</i>  <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1370926/">Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin</a>. <i>N Engl J Med</i>. 2002;346(6):393–403. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJMoa012512">10.1056/NEJMoa012512</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/11832527?dopt=Abstract">PMID 11832527</a>.</span></span></li>
<li id="cite_note-DPP10-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-DPP10_24-0">^</a></b></span> <span class="reference-text"><span class="citation">Knowler WC, Fowler SE, Hamman RF, <i>et al.</i>  <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135022/">10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study</a>. <i>Lancet</i>. 2009;374(9702):1677–86. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0140-6736%2809%2961457-4">10.1016/S0140-6736(09)61457-4</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19878986?dopt=Abstract">PMID 19878986</a>.</span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation">Lilly M, Godwin M.  <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669003/">Treating prediabetes with metformin: systematic review and meta-analysis</a>. <i>Can Fam Physician</i>. 2009;55(4):363–9. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19366942?dopt=Abstract">PMID 19366942</a>.</span></span></li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><span class="citation">Kidson W.  <a rel="nofollow" class="external text" href="http://www.mja.com.au/public/issues/nov16/kidson/kidson.html">Polycystic ovary syndrome: a new direction in treatment</a>. <i>Med J Aust</i>. 1998;169(10):537–40. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/9861912?dopt=Abstract">PMID 9861912</a>.</span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><span class="citation">Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ.  Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. <i>Metab Clin Exp</i>. 1994;43(5):647–54. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/8177055?dopt=Abstract">PMID 8177055</a>.</span></span></li>
<li id="cite_note-Teede-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-Teede_28-0">^</a></b></span> <span class="reference-text"><span class="citation">Teede H. Insulin sensitizers in polycystic ovary syndrome. In: Kovács GT, Norman RW. <i>Polycystic ovary syndrome</i>. Cambridge, UK: Cambridge University Press; 2007. <a href="/wiki/Special:BookSources/0521848490" class="internal mw-magiclink-isbn">ISBN 0-521-84849-0</a>. p. 65–81.</span></span></li>
<li id="cite_note-NICEfertility-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-NICEfertility_29-0">^</a></b></span> <span class="reference-text"><span class="citation">National Collaborating Centre for Women’s and Children's Health. <i><a rel="nofollow" class="external text" href="http://www.nice.org.uk/nicemedia/pdf/cg011fullguideline.pdf">Fertility: assessment and treatment for people with fertility problems</a></i> [pdf]. London: Royal College of Obstetricians and Gynaecologists; 2004. <a href="/wiki/Special:BookSources/1900364972" class="internal mw-magiclink-isbn">ISBN 1-900364-97-2</a>. p. 58–9.</span></span></li>
<li id="cite_note-pmid17287476-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17287476_30-0">^</a></b></span> <span class="reference-text"><span class="citation">Legro RS, Barnhart HX, Schlaff WD, <i>et al.</i>  Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. <i>N Engl J Med</i>. 2007;356(6):551–66. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJMoa063971">10.1056/NEJMoa063971</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/17287476?dopt=Abstract">PMID 17287476</a>.</span></span></li>
<li id="cite_note-pmid16769748-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16769748_31-0">^</a></b></span> <span class="reference-text"><span class="citation">Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F.  <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1482338/">Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial</a>. <i>BMJ</i>. 2006;332(7556):1485. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fbmj.38867.631551.55">10.1136/bmj.38867.631551.55</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/16769748?dopt=Abstract">PMID 16769748</a>.</span></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><span class="citation">Balen A. Royal College of Obstetricians and Gynaecologists. <a rel="nofollow" class="external text" href="http://www.rcog.org.uk/files/rcog-corp/uploaded-files/SAC13metformin-minorrevision.pdf">Metformin therapy for the management of infertility in women with polycystic ovary syndrome</a> [PDF]; December 2008 [Retrieved 2009-12-13].</span></span></li>
<li id="cite_note-pmid18308833-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18308833_33-0">^</a></b></span> <span class="reference-text"><span class="citation">The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.  Consensus on infertility treatment related to polycystic ovary syndrome. <i>Hum Reprod</i>. 2008;23(3):462–77. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Fhumrep%2Fdem426">10.1093/humrep/dem426</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/18308833?dopt=Abstract">PMID 18308833</a>.</span></span></li>
<li id="cite_note-pmid18691273-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18691273_34-0">^</a></b></span> <span class="reference-text"><span class="citation">Palomba S, Pasquali R, Orio F, Nestler JE.  Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis. <i>Clin. Endocrinol. (Oxf)</i>. 2009;70(2):311–21. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1365-2265.2008.03369.x">10.1111/j.1365-2265.2008.03369.x</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/18691273?dopt=Abstract">PMID 18691273</a>.</span></span></li>
<li id="cite_note-pmid16793784-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16793784_35-0">^</a></b></span> <span class="reference-text"><span class="citation">Al-Inany H, Johnson N.  <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1482323/">Drugs for anovulatory infertility in polycystic ovary syndrome</a>. <i>BMJ</i>. 2006;332(7556):1461–2. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fbmj.332.7556.1461">10.1136/bmj.332.7556.1461</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/16793784?dopt=Abstract">PMID 16793784</a>.</span></span></li>
<li id="cite_note-pmid19405411-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19405411_36-0">^</a></b></span> <span class="reference-text"><span class="citation">Radosh L.  Drug treatments for polycystic ovary syndrome. <i>Am Fam Physician</i>. 2009;79(8):671–6. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19405411?dopt=Abstract">PMID 19405411</a>.</span></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><span class="citation">Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH.  <a rel="nofollow" class="external text" href="http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003053/frame.html">Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility</a>. <i>Cochrane Database Syst Rev</i>. 2009;(4):CD003053. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F14651858.CD003053.pub3">10.1002/14651858.CD003053.pub3</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19821299?dopt=Abstract">PMID 19821299</a>.</span></span></li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><span class="citation">Tertti K, Ekblad U, Vahlberg T, Rönnemaa T.  <a rel="nofollow" class="external text" href="http://www.soc-bdr.org/content/rds/archive/5/2_summer/original_data/treatment_of_gestational_diabetes/index_en.html?showfulltext=1">Comparison of metformin and insulin in the treatment of gestational diabetes: a retrospective, case-control study</a>. <i>Rev Diabet Stud</i>. 2008;5(2):95–101. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1900%2FRDS.2008.5.95">10.1900/RDS.2008.5.95</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/18795211?dopt=Abstract">PMID 18795211</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556447/">2556447</a>.</span></span></li>
<li id="cite_note-MiG-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-MiG_39-0">^</a></b></span> <span class="reference-text"><span class="citation">Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators.  <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/content/full/358/19/2003">Metformin versus insulin for the treatment of gestational diabetes</a>. <i>N Engl J Med</i>. 2008;258(19):2003–15. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJMoa0707193">10.1056/NEJMoa0707193</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/18463376?dopt=Abstract">PMID 18463376</a>.</span></span></li>
<li id="cite_note-Nicholson-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nicholson_40-0">^</a></b></span> <span class="reference-text"><span class="citation">Nicholson W, Bolen S, Witkop CT, Neale D, Wilson L, Bass E.  Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. <i>Obstet Gynecol</i>. 2009;113(1):193–205. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19104375?dopt=Abstract">PMID 19104375</a>.</span></span></li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><span class="citation">Balani J, Hyer SL, Rodin DA, Shehata H.  Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study. <i>Diabet Med</i>. 2009;26(8):798–802. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19709150?dopt=Abstract">PMID 19709150</a>.</span></span></li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><span class="citation">Cheung NW.  <a rel="nofollow" class="external text" href="http://www.dovepress.com/getfile.php?fileID=4160">The management of gestational diabetes</a> [pdf]. <i>Vasc Health Risk Manag</i>. 2009;5(1):153–64. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19436673?dopt=Abstract">PMID 19436673</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672462/">2672462</a>.</span></span></li>
<li id="cite_note-Jones2003-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jones2003_43-0">^</a></b></span> <span class="reference-text"><span class="citation">Jones G, Macklin J, Alexander W.  <a rel="nofollow" class="external text" href="http://www.bmj.com/cgi/content/full/326/7379/4">Contraindications to the use of metformin</a>. <i>BMJ</i>. 2003;326(7379):4–5. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fbmj.326.7379.4">10.1136/bmj.326.7379.4</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/12511434?dopt=Abstract">PMID 12511434</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1124930/">1124930</a>.</span></span></li>
<li id="cite_note-glucopi-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-glucopi_44-0">^</a></b></span> <span class="reference-text"><span class="citation">U.S. FDA. <a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020357s031,021202s016lbl.pdf">Glucophage Prescribing Information for the U.S.</a> [PDF] [Retrieved 2009-12-24].</span></span></li>
<li id="cite_note-Eurich-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-Eurich_45-0">^</a></b></span> <span class="reference-text"><span class="citation">Eurich DT, McAlister FA, Blackburn DF, <i>et al.</i>  <a rel="nofollow" class="external text" href="http://www.bmj.com/cgi/content/full/335/7618/497">Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review</a>. <i>BMJ</i>. 2007;335(7618):497. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fbmj.39314.620174.80">10.1136/bmj.39314.620174.80</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/17761999?dopt=Abstract">PMID 17761999</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971204/">1971204</a>.</span></span></li>
<li id="cite_note-RCR-46"><span class="mw-cite-backlink">^ <a href="#cite_ref-RCR_46-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RCR_46-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Weir J (March 19, 1999). <a rel="nofollow" class="external text" href="http://web.archive.org/web/20040104141219/http://www.rcr.ac.uk/pubtop.asp?PublicationID=70">Guidelines with Regard to Metformin-Induced Lactic Acidosis and X-ray Contrast Medium Agents</a>. <a href="/wiki/Royal_College_of_Radiologists" title="Royal College of Radiologists">Royal College of Radiologists</a>. Retrieved October 26, 2007 through the <a href="/wiki/Internet_Archive" title="Internet Archive">Internet Archive</a>.</span></li>
<li id="cite_note-ESUR-47"><span class="mw-cite-backlink">^ <a href="#cite_ref-ESUR_47-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ESUR_47-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation">Thomsen HS, Morcos SK.  <a rel="nofollow" class="external text" href="http://bjr.birjournals.org/cgi/content/full/76/908/513">Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines</a>. <i>Br J Radiol</i>. 2003;76(908):513–8. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1259%2Fbjr%2F26964464">10.1259/bjr/26964464</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/12893691?dopt=Abstract">PMID 12893691</a>.</span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation">Khurana R, Malik IS.  Metformin: safety in cardiac patients. <i>Heart</i>. 2010;96(2):99–102. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fhrt.2009.173773">10.1136/hrt.2009.173773</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19564648?dopt=Abstract">PMID 19564648</a>.</span></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><span class="citation">Vigersky RA, Filmore-Nassar A, Glass AR.  <a rel="nofollow" class="external text" href="http://jcem.endojournals.org/cgi/content/full/91/1/225">Thyrotropin suppression by metformin</a>. <i>J Clin Endocrinol Metab</i>. 2006;91(1):225–7. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1210%2Fjc.2005-1210">10.1210/jc.2005-1210</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/16219720?dopt=Abstract">PMID 16219720</a>.</span></span></li>
<li id="cite_note-DF.26C-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-DF.26C_50-0">^</a></b></span> <span class="reference-text"><span class="citation"><i>Drug Facts and Comparisons 2005</i>. St. Louis, Mo: Facts and Comparisons; 2004. <a href="/wiki/Special:BookSources/1574391933" class="internal mw-magiclink-isbn">ISBN 1-57439-193-3</a>.</span></span></li>
<li id="cite_note-Wulffele-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-Wulffele_51-0">^</a></b></span> <span class="reference-text"><span class="citation">Wulffele MG, Kooy A, Lehert P, Bets D, Ogterop JC, Borger van der Burg B, Donker AJ, Stehouwer CD.  <a rel="nofollow" class="external text" href="http://www3.interscience.wiley.com/cgi-bin/fulltext/118889232/HTMLSTART">Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial</a>. <i>J Intern Med</i>. 2003;254(5):455–63. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1046%2Fj.1365-2796.2003.01213.x">10.1046/j.1365-2796.2003.01213.x</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/14535967?dopt=Abstract">PMID 14535967</a>.</span></span></li>
<li id="cite_note-Andres-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-Andres_52-0">^</a></b></span> <span class="reference-text"><span class="citation">Andrès E, Noel E, Goichot B.  Metformin-associated vitamin B12 deficiency. <i>Arch Intern Med</i>. 2002;162(19):2251–2. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Farchinte.162.19.2251-a">10.1001/archinte.162.19.2251-a</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/12390080?dopt=Abstract">PMID 12390080</a>.</span></span></li>
<li id="cite_note-Gilligan-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gilligan_53-0">^</a></b></span> <span class="reference-text"><span class="citation">Gilligan M.  Metformin and vitamin B12 deficiency. <i>Arch Intern Med</i>. 2002;162(4):484–5. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Farchinte.162.4.484">10.1001/archinte.162.4.484</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/11863489?dopt=Abstract">PMID 11863489</a>.</span></span></li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><span class="citation journal">de Jager J, Kooy A, Lehert P, <i>et al.</i> (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2874129">"Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial"</a>. <i>BMJ</i> <b>340</b>: c2181. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fbmj.c2181">10.1136/bmj.c2181</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2874129">2874129</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20488910">20488910</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetformin&amp;rft.atitle=Long+term+treatment+with+metformin+in+patients+with+type+2+diabetes+and+risk+of+vitamin+B-12+deficiency%3A+randomised+placebo+controlled+trial&amp;rft.au=de+Jager+J%2C+Kooy+A%2C+Lehert+P%2C+%27%27et+al.%27%27&amp;rft.aulast=de+Jager+J%2C+Kooy+A%2C+Lehert+P%2C+%27%27et+al.%27%27&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2874129&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.c2181&amp;rft_id=info%3Apmc%2F2874129&amp;rft_id=info%3Apmid%2F20488910&amp;rft.jtitle=BMJ&amp;rft.pages=c2181&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=340" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><span class="citation">Ting R, Szeto C, Chan M, Ma K, Chow K.  <a rel="nofollow" class="external text" href="http://archinte.ama-assn.org/cgi/content/full/166/18/1975">Risk factors of vitamin B(12) deficiency in patients receiving metformin</a>. <i>Arch Intern Med</i>. 2006;166(18):1975–9. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Farchinte.166.18.1975">10.1001/archinte.166.18.1975</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/17030830?dopt=Abstract">PMID 17030830</a>.</span></span></li>
<li id="cite_note-Stang-56"><span class="mw-cite-backlink">^ <a href="#cite_ref-Stang_56-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Stang_56-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Stang M, Wysowski D K, Butler-Jones D (1999). "Incidence of lactic acidosis in metformin users". <i>Diabetes Care</i> <b>22</b> (6): 925–927. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2337%2Fdiacare.22.6.925">10.2337/diacare.22.6.925</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10372243">10372243</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetformin&amp;rft.atitle=Incidence+of+lactic+acidosis+in+metformin+users&amp;rft.aulast=Stang+M%2C+Wysowski+D+K%2C+Butler-Jones+D&amp;rft.au=Stang+M%2C+Wysowski+D+K%2C+Butler-Jones+D&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2337%2Fdiacare.22.6.925&amp;rft_id=info%3Apmid%2F10372243&amp;rft.issue=6&amp;rft.jtitle=Diabetes+Care&amp;rft.pages=925%26ndash%3B927&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Salpeter-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-Salpeter_57-0">^</a></b></span> <span class="reference-text"><span class="citation">Salpeter S, Greyber E, Pasternak G, Salpeter E.  <a rel="nofollow" class="external text" href="http://archinte.ama-assn.org/cgi/content/full/163/21/2594">Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis</a>. <i><a href="/wiki/Archives_of_Internal_Medicine" title="Archives of Internal Medicine" class="mw-redirect">Arch Intern Med</a></i>. 2003;163(21):2594–602. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1001%2Farchinte.163.21.2594">10.1001/archinte.163.21.2594</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/14638559?dopt=Abstract">PMID 14638559</a>.</span></span></li>
<li id="cite_note-Golan-58"><span class="mw-cite-backlink">^ <a href="#cite_ref-Golan_58-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Golan_58-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation">Shu AD, Myers Jr MG, Shoelson SE. Chapter 29: Pharmacology of the Endocrine Pancreas. In: Golan ED <i>et al.</i> (eds.). <i>Principles of pharmacology: the pathophysiologic basis of drug therapy</i>. Philadelphia: Lippincott, Williams &amp; Wilkins; 2005. <a href="/wiki/Special:BookSources/0781746787" class="internal mw-magiclink-isbn">ISBN 0-7817-4678-7</a>. p. 540–41.</span></span></li>
<li id="cite_note-Kirpichnikov-59"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kirpichnikov_59-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kirpichnikov_59-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation">Kirpichnikov D, McFarlane SI, Sowers JR.  <a rel="nofollow" class="external text" href="http://www.annals.org/cgi/reprint/137/1/25.pdf">Metformin: an update</a> [PDF]. <i>Ann Intern Med</i>. 2002;137(1):25–33. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/12093242?dopt=Abstract">PMID 12093242</a>.</span></span></li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><span class="citation">Davis SN. Chapter 60: Insulin, Oral Hypoglycemic Agents, and the Pharmacology of the Endocrine Pancreas. In: Brunton L, Lazo J, Parker K. <i><a href="/wiki/Goodman_%26_Gilman%27s_The_Pharmacological_Basis_of_Therapeutics" title="Goodman &amp; Gilman's The Pharmacological Basis of Therapeutics">Goodman &amp; Gilman's The Pharmacological Basis of Therapeutics</a></i>. 11th ed. New York: <a href="/wiki/McGraw-Hill" title="McGraw-Hill" class="mw-redirect">McGraw-Hill</a>; 2006. <a href="/wiki/Special:BookSources/9780071422802" class="internal mw-magiclink-isbn">ISBN 978-0-07-142280-2</a>.</span></span></li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><span class="citation">Spiller HA, Quadrani DA.  Toxic effects from metformin exposure. <i>Ann Pharmacother</i>. 2004;38(5):776–80. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1345%2Faph.1D468">10.1345/aph.1D468</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/15031415?dopt=Abstract">PMID 15031415</a>.</span></span></li>
<li id="cite_note-Forrester-62"><span class="mw-cite-backlink">^ <a href="#cite_ref-Forrester_62-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Forrester_62-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation">Forrester MB.  Adult metformin ingestions reported to Texas poison control centers, 2000–2006. <i>Hum Exp Toxicol</i>. 2008;27(7):575–83. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1177%2F0960327108090589">10.1177/0960327108090589</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/18829734?dopt=Abstract">PMID 18829734</a>.</span></span></li>
<li id="cite_note-63g-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63g_63-0">^</a></b></span> <span class="reference-text"><span class="citation">Gjedde S, Christiansen A, Pedersen SB, Rungby J.  Survival following a metformin overdose of 63 g: a case report. <i>Pharmacol Toxicol</i>. 2003;93(2):98–9. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1034%2Fj.1600-0773.2003.930207.x">10.1034/j.1600-0773.2003.930207.x</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/12899672?dopt=Abstract">PMID 12899672</a>.</span></span></li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><span class="citation">Nisse P, Mathieu-Nolf M, Deveaux M, Forceville X, Combes A.  A fatal case of metformin poisoning. <i>J Toxicol Clin Toxicol</i>. 2003;41(7):1035–6. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1081%2FCLT-120026533">10.1081/CLT-120026533</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/14705855?dopt=Abstract">PMID 14705855</a>.</span></span></li>
<li id="cite_note-Suchard-65"><span class="mw-cite-backlink">^ <a href="#cite_ref-Suchard_65-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Suchard_65-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation">Suchard JR, Grotsky TA.  <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672258/">Fatal metformin overdose presenting with progressive hyperglycemia</a>. <i>West J Emerg Med</i>. 2008;9(3):160–4. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19561734?dopt=Abstract">PMID 19561734</a>.</span></span></li>
<li id="cite_note-Teale-66"><span class="mw-cite-backlink">^ <a href="#cite_ref-Teale_66-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Teale_66-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation">Teale KF, Devine A, Stewart H, Harper NJ.  The management of metformin overdose. <i>Anaesthesia</i>. 1998;53(7):698–701. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1046%2Fj.1365-2044.1998.436-az0549.x">10.1046/j.1365-2044.1998.436-az0549.x</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/9771180?dopt=Abstract">PMID 9771180</a>.</span></span></li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><span class="citation">Spiller HA, Weber JA, Winter ML, Klein-Schwartz W, Hofman M, Gorman SE, Stork CM, Krenzelok EP.  Multicenter case series of pediatric metformin ingestion. <i>Ann Pharmacother</i>. 2000;34(12):1385–8. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1345%2Faph.10116">10.1345/aph.10116</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/11144693?dopt=Abstract">PMID 11144693</a>.</span></span></li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><span class="citation">Dell'Aglio DM, Perino LJ, Kazzi Z, Abramson J, Schwartz MD, Morgan BW.  Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature. <i>Ann Emerg Med</i>. 2009;54(6):818–23. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.annemergmed.2009.04.023">10.1016/j.annemergmed.2009.04.023</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19556031?dopt=Abstract">PMID 19556031</a>.</span></span></li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><span class="citation">Lacher M, Hermanns-Clausen M, Haeffner K, Brandis M, Pohl M.  Severe metformin intoxication with lactic acidosis in an adolescent. <i>Eur J Pediatr</i>. 2005;164(6):362–5. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs00431-005-1634-y">10.1007/s00431-005-1634-y</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/15729560?dopt=Abstract">PMID 15729560</a>.</span></span></li>
<li id="cite_note-cvvh-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-cvvh_70-0">^</a></b></span> <span class="reference-text"><span class="citation">Harvey B, Hickman C, Hinson G, Ralph T, Mayer A.  Severe lactic acidosis complicating metformin overdose successfully treated with high-volume venovenous hemofiltration and aggressive alkalinization. <i>Pediatr Crit Care Med</i>. 2005;6(5):598–601. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2F01.PCC.0000162451.47034.4F">10.1097/01.PCC.0000162451.47034.4F</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/16148825?dopt=Abstract">PMID 16148825</a>.</span></span></li>
<li id="cite_note-hd-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-hd_71-0">^</a></b></span> <span class="reference-text"><span class="citation">Guo PY, Storsley LJ, Finkle SN.  Severe lactic acidosis treated with prolonged hemodialysis: recovery after massive overdoses of metformin. <i>Semin Dial</i>. 2006;19(1):80–3. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1525-139X.2006.00123.x">10.1111/j.1525-139X.2006.00123.x</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/16423187?dopt=Abstract">PMID 16423187</a>.</span></span></li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><span class="citation">Barrueto F, Meggs WJ, Barchman MJ.  Clearance of metformin by hemofiltration in overdose. <i>J Toxicol Clin Toxicol</i>. 2002;40(2):177–80. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1081%2FCLT-120004407">10.1081/CLT-120004407</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/12126190?dopt=Abstract">PMID 12126190</a>.</span></span></li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text">Liu A, Coleman SP. Determination of metformin in human plasma using hydrophilic interaction liquid chromatography-tandem mass spectrometry. <i>J. Chrom. B</i> 877: 3695–3700, 2009.</span></li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text">R. Baselt, <i>Disposition of Toxic Drugs and Chemicals in Man</i>, 8th edition, Biomedical Publications, Foster City, CA, 2008, pp. 939–940.</span></li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><span class="citation">Somogyi A, Stockley C, Keal J, Rolan P, Bochner F.  <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1386190/">Reduction of metformin renal tubular secretion by cimetidine in man</a>. <i>Br J Clin Pharmacol</i>. 1987;23(5):545–51. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/3593625?dopt=Abstract">PMID 3593625</a>.</span></span></li>
<li id="cite_note-PI-76"><span class="mw-cite-backlink">^ <a href="#cite_ref-PI_76-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PI_76-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-PI_76-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-PI_76-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-PI_76-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-PI_76-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-PI_76-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-PI_76-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation"><a href="/wiki/Bristol-Myers_Squibb" title="Bristol-Myers Squibb">Bristol-Myers Squibb</a>. U.S. Food and Drug Administration. <a rel="nofollow" class="external text" href="http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020357s031,021202s016lbl.pdf">Glucophage (metformin hydrochloride tablets) Label Information</a>; August 27, 2008 [Retrieved 2009-12-08].</span></span></li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><span class="citation">Jayasagar G, Krishna Kumar M, Chandrasekhar K, Madhusudan Rao C, Madhusudan Rao Y.  Effect of cephalexin on the pharmacokinetics of metformin in healthy human volunteers. <i>Drug Metabol Drug Interact</i>. 2002;19(1):41–8. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/12222753?dopt=Abstract">PMID 12222753</a>.</span></span></li>
<li id="cite_note-Hundal-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hundal_78-0">^</a></b></span> <span class="reference-text"><span class="citation">Hundal R, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi S, Schumann W, Petersen K, Landau B, Shulman G.  <a rel="nofollow" class="external text" href="http://diabetes.diabetesjournals.org/cgi/reprint/49/12/2063">Mechanism by which metformin reduces glucose production in type 2 diabetes</a> [PDF]. <i>Diabetes</i>. 2000;49(12):2063–9. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2337%2Fdiabetes.49.12.2063">10.2337/diabetes.49.12.2063</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/11118008?dopt=Abstract">PMID 11118008</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995498/">2995498</a>.</span></span></li>
<li id="cite_note-Rena_2013-79"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rena_2013_79-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rena_2013_79-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Rena_2013_79-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Rena G, Pearson ER, Sakamoto K (September 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3737434">"Molecular mechanism of action of metformin: old or new insights?"</a>. <i>Diabetologia</i> <b>56</b> (9): 1898–906. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1007%2Fs00125-013-2991-0">10.1007/s00125-013-2991-0</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3737434">3737434</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23835523">23835523</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetformin&amp;rft.atitle=Molecular+mechanism+of+action+of+metformin%3A+old+or+new+insights%3F&amp;rft.aulast=Rena+G%2C+Pearson+ER%2C+Sakamoto+K&amp;rft.au=Rena+G%2C+Pearson+ER%2C+Sakamoto+K&amp;rft.date=September+2013&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3737434&amp;rft_id=info%3Adoi%2F10.1007%2Fs00125-013-2991-0&amp;rft_id=info%3Apmc%2F3737434&amp;rft_id=info%3Apmid%2F23835523&amp;rft.issue=9&amp;rft.jtitle=Diabetologia&amp;rft.pages=1898%E2%80%93906&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=56" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Burcelin-80"><span class="mw-cite-backlink">^ <a href="#cite_ref-Burcelin_80-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Burcelin_80-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Burcelin R (July 2013). "The antidiabetic gutsy role of metformin uncovered?". <i>Gut</i>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1136%2Fgutjnl-2013-305370">10.1136/gutjnl-2013-305370</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23840042">23840042</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetformin&amp;rft.atitle=The+antidiabetic+gutsy+role+of+metformin+uncovered%3F&amp;rft.au=Burcelin+R&amp;rft.aulast=Burcelin+R&amp;rft.date=July+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fgutjnl-2013-305370&amp;rft_id=info%3Apmid%2F23840042&amp;rft.jtitle=Gut&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><span class="citation">Towler MC, Hardie DG.  <a rel="nofollow" class="external text" href="http://circres.ahajournals.org/cgi/content/full/100/3/328">AMP-activated protein kinase in metabolic control and insulin signaling</a>. <i>Circ Res</i>. 2007;100(3):328–41. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1161%2F01.RES.0000256090.42690.05">10.1161/01.RES.0000256090.42690.05</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/17307971?dopt=Abstract">PMID 17307971</a>.</span></span></li>
<li id="cite_note-Zhou-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-Zhou_82-0">^</a></b></span> <span class="reference-text"><span class="citation">Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman M, Goodyear L, Moller D.  <a rel="nofollow" class="external text" href="http://www.jci.org/cgi/content/full/108/8/1167">Role of AMP-activated protein kinase in mechanism of metformin action</a>. <i>J Clin Invest</i>. 2001;108(8):1167–74. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1172%2FJCI13505">10.1172/JCI13505</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/11602624?dopt=Abstract">PMID 11602624</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC209533/">209533</a>.</span></span></li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><span class="citation">Kim YD, Park KG, Lee YS, <i>et al.</i>  <a rel="nofollow" class="external text" href="http://diabetes.diabetesjournals.org/cgi/content/full/57/2/306">Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP</a>. <i>Diabetes</i>. 2008;57(2):306–14. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2337%2Fdb07-0381">10.2337/db07-0381</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/17909097?dopt=Abstract">PMID 17909097</a>.</span></span></li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><span class="citation">Zhang L, He H, Balschi JA.  <a rel="nofollow" class="external text" href="http://ajpheart.physiology.org/cgi/content/full/293/1/H457">Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration</a>. <i>Am J Physiol Heart Circ Physiol</i>. 2007;293(1):H457–66. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1152%2Fajpheart.00002.2007">10.1152/ajpheart.00002.2007</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/17369473?dopt=Abstract">PMID 17369473</a>.</span></span></li>
<li id="cite_note-Miller2013-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-Miller2013_85-0">^</a></b></span> <span class="reference-text">Miller RA, Chu Q, Xie J, Foretz M, Viollet B, Birnbaum MJ. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature. 2013 Feb 14;494(7436):256-60. doi: 10.1038/nature11808. Epub 2013 Jan 6. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/23292513?dopt=Abstract">PMID 23292513</a></span></li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><span class="citation">Collier CA, Bruce CR, Smith AC, Lopaschuk G, Dyck DJ.  <a rel="nofollow" class="external text" href="http://ajpendo.physiology.org/cgi/content/full/291/1/E182">Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle</a>. <i>Am J Physiol Endocrinol Metab</i>. 2006;291(1):E182–E189. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1152%2Fajpendo.00272.2005">10.1152/ajpendo.00272.2005</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/16478780?dopt=Abstract">PMID 16478780</a>.</span></span></li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><span class="citation">Bailey CJ, Turner RC.  Metformin. <i>N Engl J Med</i>. 1996;334(9):574–9. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJM199602293340906">10.1056/NEJM199602293340906</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/8569826?dopt=Abstract">PMID 8569826</a>.</span></span></li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><span class="citation">Fantus IG, Brosseau R.  Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo. <i>J Clin Endocrinol Metab</i>. 1986;63(4):898-905.</span></span></li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><span class="citation">Musi N, Hirshman MF, Nygren J, <i>et al.</i>  <a rel="nofollow" class="external text" href="http://diabetes.diabetesjournals.org/cgi/content/full/51/7/2074">Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes</a>. <i>Diabetes</i>. 2002;51(7):2074–81. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2337%2Fdiabetes.51.7.2074">10.2337/diabetes.51.7.2074</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/12086935?dopt=Abstract">PMID 12086935</a>.</span></span></li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><span class="citation">Saeedi R, Parsons HL, Wambolt RB, <i>et al.</i>  <a rel="nofollow" class="external text" href="http://ajpheart.physiology.org/cgi/content/full/294/6/H2497">Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms</a>. <i>Am J Physiol Heart Circ Physiol</i>. 2008;294(6):H2497–506. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1152%2Fajpheart.00873.2007">10.1152/ajpheart.00873.2007</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/18375721?dopt=Abstract">PMID 18375721</a>.</span></span></li>
<li id="cite_note-werner-91"><span class="mw-cite-backlink">^ <a href="#cite_ref-werner_91-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-werner_91-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation">Werner E, Bell J.  The preparation of methylguanidine, and of ββ-dimethylguanidine by the interaction of dicyanodiamide, and methylammonium and dimethylammonium chlorides respectively. <i>J Chem Soc, Transactions</i>. 1921;121:1790–5. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1039%2FCT9222101790">10.1039/CT9222101790</a>.</span></span></li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text"><span class="citation">Shapiro SL, Parrino VA, Freedman L.  Hypoglycemic Agents. I Chemical Properties of β-Phenethylbiguanide. A New Hypoglycemic Agent. <i><a href="/wiki/J_Am_Chem_Soc" title="J Am Chem Soc" class="mw-redirect">J Am Chem Soc</a></i>. 1959;81(9):2220–5. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1021%2Fja01518a052">10.1021/ja01518a052</a>.</span></span></li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><span class="citation">Procédé de préparation de chlorhydrate de diméthylbiguanide. <i>Patent FR 2322860</i>. 1975. French.</span></span></li>
<li id="cite_note-isbn0-8155-1526-X-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-isbn0-8155-1526-X_94-0">^</a></b></span> <span class="reference-text"><span class="citation"><i>Pharmaceutical Manufacturing Encyclopedia (Sittig's Pharmaceutical Manufacturing Encyclopedia)</i>. 3rd ed. Vol. 3. Norwich, NY: William Andrew; 2007. <a href="/wiki/Special:BookSources/081551526X" class="internal mw-magiclink-isbn">ISBN 0-8155-1526-X</a>. p. 2208.</span></span></li>
<li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><span class="citation">Bharatam PV, Patel DS, Iqbal P,.  Pharmacophoric Features of Biguanide Derivatives: An Electronic and Structural Analysis. <i><a href="/wiki/J_Med_Chem" title="J Med Chem" class="mw-redirect">J Med Chem</a></i>. 2005;48(24):7615–7622. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1021%2Fjm050602z">10.1021/jm050602z</a>.</span></span></li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><span class="citation">Patel DS, Bharatam PV.  Novel N(L)2 species with two lone pairs on nitrogen: systems isoelectronic to carbodicarbenes. <i><a href="/w/index.php?title=Chem_Commun&amp;action=edit&amp;redlink=1" class="new" title="Chem Commun (page does not exist)">Chem Commun</a></i>. 2009;(9):1064–6. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1039%2Fb816595e">10.1039/b816595e</a>.</span></span></li>
<li id="cite_note-Heller-97"><span class="mw-cite-backlink">^ <a href="#cite_ref-Heller_97-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Heller_97-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation">Heller JB.  <a rel="nofollow" class="external text" href="http://www.aspca.org/site/DocServer/vetm0407_231-234.pdf?docID=11061">Metformin overdose in dogs and cats</a>. <i>Veterinary Medicine</i>. 2007;(April):231–233.</span></span></li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text">Garry G. Graham, Jeroen Punt, Manit Arora, Richard O. Day, Matthew P. Doogue, Janna K. Duong, Timothy J. Furlong, Jerry R. Greenfield, Louise C. Greenup, Carl M. Kirkpatrick, John E. Ray, Peter Timmins and Kenneth M. Williams. Clinical Pharmacokinetics of Metformin. <i>Clin Pharmacokinet</i> 2011; 50 (2): 81-98</span></li>
<li id="cite_note-Robert-99"><span class="mw-cite-backlink">^ <a href="#cite_ref-Robert_99-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Robert_99-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation">Robert F, Fendri S, Hary L, Lacroix C, Andréjak M, Lalau JD.  <a rel="nofollow" class="external text" href="http://www.em-consulte.com/article/80210">Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjects</a>. <i>Diabetes Metab</i>. 2003;29(3):279–83. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/12909816?dopt=Abstract">PMID 12909816</a>.</span></span></li>
<li id="cite_note-Witters-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-Witters_100-0">^</a></b></span> <span class="reference-text"><span class="citation">Witters L.  <a rel="nofollow" class="external text" href="http://www.jci.org/articles/view/14178">The blooming of the French lilac</a>. <i>J Clin Invest</i>. 2001;108(8):1105–7. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1172%2FJCI14178">10.1172/JCI14178</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/11602616?dopt=Abstract">PMID 11602616</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC209536/">209536</a>.</span></span></li>
<li id="cite_note-slotta-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-slotta_101-0">^</a></b></span> <span class="reference-text">See Chemical Abstracts, v.23, 42772 (1929) <span class="citation">K. H. Slotta, R. Tschesche.  Uber Biguanide. II. Die Blutzuckersenkende Wirkung der Biguanides. <i>Berichte der Deutschen Chemischen Gesellschaft B: Abhandlungen</i>. 1929;62:1398–1405. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fcber.19290620605">10.1002/cber.19290620605</a>.</span></span></li>
<li id="cite_note-fifty-102"><span class="mw-cite-backlink">^ <a href="#cite_ref-fifty_102-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-fifty_102-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation">Campbell IW.  Metformin—life begins at 50: A symposium held on the occasion of the 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam, The Netherlands, September 2007. <i>The British Journal of Diabetes &amp; Vascular Disease</i>. 2007;7:247–252. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1177%2F14746514070070051001">10.1177/14746514070070051001</a>.</span></span></li>
<li id="cite_note-pmid15405470-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15405470_103-0">^</a></b></span> <span class="reference-text"><span class="citation">Dawes GS, Mott JC.  <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1509951/">Circulatory and respiratory reflexes caused by aromatic guanidines</a>. <i>Br J Pharmacol Chemother</i>. 1950;5(1):65–76. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/15405470?dopt=Abstract">PMID 15405470</a>.</span></span></li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text">About Eusebio Y. Garcia, see: <span class="citation">Carteciano J. Philippines Department of Science and Technology. <a rel="nofollow" class="external text" href="http://sntpost.stii.dost.gov.ph/frames/aprtojun05/Search_for_DOST_NRCP_13to14.htm">Search for DOST-NRCP Dr. Eusebio Y. Garcia Award</a>; 2005 [Retrieved 2009-12-05].</span></span></li>
<li id="cite_note-Garcia-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-Garcia_105-0">^</a></b></span> <span class="reference-text">Quoted from Chemical Abstracts, v.45, 24828 (1951) <span class="citation">Garcia EY.  Fluamine, a new synthetic analgesic and antiflu drug. <i>J Philippine Med Assoc</i>. 1950;26:287–93.</span></span></li>
<li id="cite_note-pmid16766803-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16766803_106-0">^</a></b></span> <span class="reference-text">About Janusz Supniewski, see: <span class="citation">Wołkow PP, Korbut R.  <a rel="nofollow" class="external text" href="http://www.jpp.krakow.pl/journal/archive/0406_s1/pdf/119_0406_s1_article.pdf">Pharmacology at the Jagiellonian University in Kracow, short review of contribution to global science and cardiovascular research through 400 years of history</a> [pdf]. <i>J Physiol Pharmacol</i>. 2006 [Retrieved 2009-12-05];57 Suppl 1:119–36. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/16766803?dopt=Abstract">PMID 16766803</a>.</span></span></li>
<li id="cite_note-pmid13269290-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid13269290_107-0">^</a></b></span> <span class="reference-text">See Chemical Abstracts, v. 52, 22272 (1958) <span class="citation">Supniewski J, Chrusciel T.  [N-dimethyl-di-guanide and its biological properties.]. <i>Arch Immunol Ther Exp (Warsz)</i>. 1954;2:1–15. Polish. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/13269290?dopt=Abstract">PMID 13269290</a>.</span></span></li>
<li id="cite_note-supniewski2-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-supniewski2_108-0">^</a></b></span> <span class="reference-text">Quoted from Chemical Abstracts, v.49, 74699 (1955) <span class="citation">Supniewski J, Krupinska, J.  [Effect of biguanide derivatives on experimental cowpox in rabbits.]. <i>Bulletin de l'Academie Polonaise des Sciences, Classe 3: Mathematique, Astronomie, Physique, Chimie, Geologie et Geographie</i>. 1954;2(Classe II):161–5. French.</span></span></li>
<li id="cite_note-pmid16402501-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16402501_109-0">^</a></b></span> <span class="reference-text"><span class="citation">Hadden DR.  <a rel="nofollow" class="external text" href="http://www.rcpe.ac.uk/journal/issue/journal_35_3/hadden_goats%20rue.pdf">Goat's rue – French lilac – Italian fitch – Spanish sainfoin: gallega officinalis and metformin: the Edinburgh connection</a>. <i>J R Coll Physicians Edinb</i>. 2005;35(3):258–60. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/16402501?dopt=Abstract">PMID 16402501</a>.</span></span></li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><span class="citation">Lucis OJ.  <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1874707/">The status of metformin in Canada</a>. <i>Can Med Assoc J</i>. 1983;128(1):24–6. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/6847752?dopt=Abstract">PMID 6847752</a>.</span></span></li>
<li id="cite_note-FDAapproval-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDAapproval_111-0">^</a></b></span> <span class="reference-text"><span class="citation pressrelease">Susan M. Cruzan (December 30, 1994). <a rel="nofollow" class="external text" href="http://web.archive.org/web/20070929152824/http://www.fda.gov/bbs/topics/ANSWERS/ANS00627.html">"FDA Approves New Diabetes Drug"</a> (Press release). U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>. Archived from <a rel="nofollow" class="external text" href="http://www.fda.gov/bbs/topics/ANSWERS/ANS00627.html">the original</a> on September 29, 2007<span class="reference-accessdate">. Retrieved 2007-01-06</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetformin&amp;rft.aulast=Susan+M.+Cruzan&amp;rft.au=Susan+M.+Cruzan&amp;rft.btitle=FDA+Approves+New+Diabetes+Drug&amp;rft.date=December+30%2C+1994&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fbbs%2Ftopics%2FANSWERS%2FANS00627.html&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text">Glucophage Label and Approval History. U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>. Retrieved January 8, 2007. Data available for download on <a rel="nofollow" class="external text" href="http://www.fda.gov/Drugs/InformationOnDrugs/ucm079750.htm">FDA website</a>.</span></li>
<li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.rxwiki.com/Metformin">http://www.rxwiki.com/Metformin</a></span></li>
<li id="cite_note-FDC-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDC_114-0">^</a></b></span> <span class="reference-text"><span class="citation">Bailey CJ, Day C.  Fixed-dose single tablet antidiabetic combinations. <i>Diabetes Obes Metab</i>. 2009;11(6):527–33. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1463-1326.2008.00993.x">10.1111/j.1463-1326.2008.00993.x</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/19175373?dopt=Abstract">PMID 19175373</a>.</span></span></li>
<li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><span class="citation pressrelease"><a rel="nofollow" class="external text" href="http://www.docguide.com/news/content.nsf/news/8525697700573E1885256C4F0075B2B3">"FDA Approves GlaxoSmithKline's Avandamet (rosiglitazone maleate and metformin HCl), The Latest Advancement in the Treatment of Type 2 Diabetes"</a> (Press release). <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a>. October 12, 2002<span class="reference-accessdate">. Retrieved 2006-12-27</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetformin&amp;rft.btitle=FDA+Approves+GlaxoSmithKline%27s+Avandamet+%28rosiglitazone+maleate+and+metformin+HCl%29%2C+The+Latest+Advancement+in+the+Treatment+of+Type+2+Diabetes&amp;rft.date=October+12%2C+2002&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.docguide.com%2Fnews%2Fcontent.nsf%2Fnews%2F8525697700573E1885256C4F0075B2B3&amp;rft.pub=GlaxoSmithKline&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><span class="PDFlink"><a rel="nofollow" class="external text" href="http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/252010/674969/article.pdf">2009 Top 200 branded drugs by total prescriptions</a></span><span style="font-size:smaller;">&#160;PDF&#160;(96.5&#160;KB)</span>. <i>Drug Topics</i> (June 17, 2010). Retrieved September 2, 2010.</span></li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><span class="citation pressrelease"><a rel="nofollow" class="external text" href="http://web.archive.org/web/20071014014507/http://www.fda.gov/oc/qanda/PaxilandAvandamet.html">"Questions and Answers about the Seizure of Paxil CR and Avandamet"</a> (Press release). U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>. March 4, 2005. Archived from <a rel="nofollow" class="external text" href="http://www.fda.gov/oc/qanda/PaxilandAvandamet.html">the original</a> on October 14, 2007<span class="reference-accessdate">. Retrieved 2006-12-27</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetformin&amp;rft.btitle=Questions+and+Answers+about+the+Seizure+of+Paxil+CR+and+Avandamet&amp;rft.date=March+4%2C+2005&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Foc%2Fqanda%2FPaxilandAvandamet.html&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text"><span class="citation pressrelease"><a rel="nofollow" class="external text" href="http://www.reuters.com/article/inPlayBriefing/idUSIN20070927170530TEVA20070927">"Teva Pharm announces settlement of generic Avandia, Avandamet, and Avandaryl litigation with GlaxoSmithKline"</a> (Press release). Reuters. September 27, 2007<span class="reference-accessdate">. Retrieved 2009-02-17</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetformin&amp;rft.btitle=Teva+Pharm+announces+settlement+of+generic+Avandia%2C+Avandamet%2C+and+Avandaryl+litigation+with+GlaxoSmithKline&amp;rft.date=September+27%2C+2007&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.reuters.com%2Farticle%2FinPlayBriefing%2FidUSIN20070927170530TEVA20070927&amp;rft.pub=Reuters&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002279/smops/Positive/human_smop_000377.jsp&amp;mid=WC0b01ac058001d127">Jentadueto</a> at the European Medicines Agency. First published 25/05/2012</span></li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><span class="citation journal">Malek, M; Aghili, R; Emami, Z; Khamseh, ME (2013). "Risk of Cancer in Diabetes: The Effect of Metformin.". <i>ISRN endocrinology</i> <b>2013</b>: 636927. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1155%2F2013%2F636927">10.1155/2013/636927</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24224094">24224094</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMetformin&amp;rft.atitle=Risk+of+Cancer+in+Diabetes%3A+The+Effect+of+Metformin.&amp;rft.aufirst=M&amp;rft.aulast=Malek&amp;rft.au=Malek%2C+M&amp;rft.date=2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1155%2F2013%2F636927&amp;rft_id=info%3Apmid%2F24224094&amp;rft.jtitle=ISRN+endocrinology&amp;rft.pages=636927&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2013" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameters (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-pmid20442309-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20442309_121-0">^</a></b></span> <span class="reference-text"><span class="citation">Ben Sahra I, Le Marchand Brustel Y, Tanti JF, Bost F.  Metformin in cancer therapy: a new perspective for an old antidiabetic drug?. <i>Mol Cancer Therapeutics</i>. 2010;9(5):1092–99. <a href="/wiki/Digital_Object_Identifier" title="Digital Object Identifier" class="mw-redirect">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1158%2F1535-7163.MCT-09-1186">10.1158/1535-7163.MCT-09-1186</a>. <a class="external mw-magiclink-pmid" rel="nofollow" href="//www.ncbi.nlm.nih.gov/pubmed/20442309?dopt=Abstract">PMID 20442309</a>.</span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Metformin&amp;action=edit&amp;section=21" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="noprint tright portal" style="border:solid #aaa 1px;margin:0.5em 0 0.5em 1em;">
<table style="background:#f9f9f9;font-size:85%;line-height:110%;max-width:175px;">
<tr valign="middle">
<td style="text-align:center;"><a href="/wiki/File:Tabletten.JPG" class="image"><img alt="Portal icon" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Tabletten.JPG/32px-Tabletten.JPG" width="32" height="26" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Tabletten.JPG/48px-Tabletten.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/5f/Tabletten.JPG/64px-Tabletten.JPG 2x" /></a></td>
<td style="padding:0 0.2em;vertical-align:middle;font-style:italic;font-weight:bold;"><a href="/wiki/Portal:Pharmacy_and_Pharmacology" title="Portal:Pharmacy and Pharmacology">Pharmacy and Pharmacology portal</a></td>
</tr>
</table>
</div>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.dmoz.org/Health/Pharmacy/Drugs_and_Medications/M/Metformin">Metformin</a> on the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
<li><a rel="nofollow" class="external text" href="http://www.merck.com/mmpe/lexicomp/metformin.html">Metformin drug information</a> from Lexi-Comp. Includes dosage information and a comprehensive list of international brand names</li>
<li><a rel="nofollow" class="external text" href="http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Metformin">U.S. National Library of Medicine: Drug Information Portal – Metformin</a></li>
</ul>
<p><br style="clear:both;" /></p>
<table cellspacing="0" class="navbox" style="border-spacing:0;">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks navbox-inner" style="border-spacing:0;background:transparent;color:inherit;">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Oral_hypoglycemics_and_insulin_analogs" title="Template:Oral hypoglycemics and insulin analogs"><span title="View this template" style=";;background:none transparent;border:none;;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Oral_hypoglycemics_and_insulin_analogs" title="Template talk:Oral hypoglycemics and insulin analogs"><span title="Discuss this template" style=";;background:none transparent;border:none;;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Oral_hypoglycemics_and_insulin_analogs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%;">Oral <a href="/wiki/Anti-diabetic_drug" title="Anti-diabetic drug" class="mw-redirect">anti-diabetic drugs</a> and <a href="/wiki/Insulin_analog" title="Insulin analog">Insulin analogs</a> (<a href="/wiki/ATC_code_A10" title="ATC code A10">A10</a>)</div>
</th>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:#fd6;;"><a href="/wiki/Insulin" title="Insulin">Insulin</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Anti-diabetic_drug#Sensitizers" title="Anti-diabetic drug" class="mw-redirect">Sensitizers</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Biguanide" title="Biguanide">Biguanides</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><strong class="selflink">Metformin</strong><sup>#</sup></li>
<li><a href="/wiki/Buformin" title="Buformin">Buformin</a><sup>‡</sup></li>
<li><a href="/wiki/Phenformin" title="Phenformin">Phenformin</a><sup>‡</sup></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Thiazolidinedione" title="Thiazolidinedione">TZDs</a>/"glitazones" (<a href="/wiki/PPAR_agonist" title="PPAR agonist">PPAR</a>)</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Pioglitazone" title="Pioglitazone">Pioglitazone</a></li>
<li><a href="/wiki/Rivoglitazone" title="Rivoglitazone">Rivoglitazone</a><sup>†</sup></li>
<li><a href="/wiki/Rosiglitazone" title="Rosiglitazone">Rosiglitazone</a></li>
<li><a href="/wiki/Troglitazone" title="Troglitazone">Troglitazone</a><sup>‡</sup></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/PPAR_agonist#Dual_PPAR_agonists" title="PPAR agonist">Dual PPAR agonists</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Aleglitazar" title="Aleglitazar">Aleglitazar</a><sup>†</sup></li>
<li><a href="/wiki/Muraglitazar" title="Muraglitazar">Muraglitazar</a><sup>§</sup></li>
<li><a href="/wiki/Saroglitazar" title="Saroglitazar">Saroglitazar</a></li>
<li><a href="/wiki/Tesaglitazar" title="Tesaglitazar">Tesaglitazar</a><sup>§</sup></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Anti-diabetic_drug#Secretagogues" title="Anti-diabetic drug" class="mw-redirect">Secretagogues</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/ATP-sensitive_potassium_channel" title="ATP-sensitive potassium channel">K+ ATP</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Sulfonylurea" title="Sulfonylurea">Sulfonylureas</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i><a href="/wiki/Sulfonylurea#First_generation" title="Sulfonylurea">1st generation</a></i>: <a href="/wiki/Acetohexamide" title="Acetohexamide">Acetohexamide</a></li>
<li><a href="/wiki/Carbutamide" title="Carbutamide">Carbutamide</a></li>
<li><a href="/wiki/Chlorpropamide" title="Chlorpropamide">Chlorpropamide</a></li>
<li><a href="/wiki/Metahexamide" title="Metahexamide">Metahexamide</a></li>
<li><a href="/wiki/Tolbutamide" title="Tolbutamide">Tolbutamide</a></li>
<li><a href="/wiki/Tolazamide" title="Tolazamide">Tolazamide</a></li>
</ul>
<p><i><a href="/wiki/Sulfonylurea#Second_generation" title="Sulfonylurea">2nd generation</a></i>: <a href="/wiki/Glibenclamide" title="Glibenclamide">Glibenclamide (Glyburide)</a><sup>#</sup></p>
<ul>
<li><a href="/wiki/Glibornuride" title="Glibornuride">Glibornuride</a></li>
<li><a href="/wiki/Glipizide" title="Glipizide">Glipizide</a></li>
<li><a href="/wiki/Gliquidone" title="Gliquidone">Gliquidone</a></li>
<li><a href="/wiki/Glisoxepide" title="Glisoxepide">Glisoxepide</a></li>
<li><a href="/wiki/Glyclopyramide" title="Glyclopyramide">Glyclopyramide</a></li>
<li><a href="/wiki/Glimepiride" title="Glimepiride">Glimepiride</a></li>
<li><a href="/wiki/Gliclazide" title="Gliclazide">Gliclazide</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Meglitinide" title="Meglitinide">Meglitinides</a>/"glinides"</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Nateglinide" title="Nateglinide">Nateglinide</a></li>
<li><a href="/wiki/Repaglinide" title="Repaglinide">Repaglinide</a></li>
<li><a href="/wiki/Mitiglinide" title="Mitiglinide">Mitiglinide</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Glucagon-like_peptide-1_agonist" title="Glucagon-like peptide-1 agonist">GLP-1 agonists</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Exenatide" title="Exenatide">Exenatide</a></li>
<li><a href="/wiki/Liraglutide" title="Liraglutide">Liraglutide</a></li>
<li><a href="/wiki/Taspoglutide" title="Taspoglutide">Taspoglutide</a><sup>†</sup></li>
<li><a href="/wiki/Albiglutide" title="Albiglutide">Albiglutide</a><sup>†</sup></li>
<li><a href="/wiki/Lixisenatide" title="Lixisenatide">Lixisenatide</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Dipeptidyl_peptidase-4_inhibitor" title="Dipeptidyl peptidase-4 inhibitor">DPP-4 inhibitors</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Alogliptin" title="Alogliptin">Alogliptin</a></li>
<li><a href="/wiki/Anagliptin" title="Anagliptin">Anagliptin</a></li>
<li><a href="/wiki/Gemigliptin" title="Gemigliptin">Gemigliptin</a></li>
<li><a href="/wiki/Linagliptin" title="Linagliptin">Linagliptin</a></li>
<li><a href="/wiki/Saxagliptin" title="Saxagliptin">Saxagliptin</a></li>
<li><a href="/wiki/Sitagliptin" title="Sitagliptin">Sitagliptin</a></li>
<li><a href="/wiki/Teneligliptin" title="Teneligliptin">Teneligliptin</a></li>
<li><a href="/wiki/Vildagliptin" title="Vildagliptin">Vildagliptin</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;">GPR40 <a href="/wiki/Free_fatty_acid_receptor_1" title="Free fatty acid receptor 1">Free fatty acid receptor 1</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li>Fasiglifam<sup>†</sup></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Insulin_analog" title="Insulin analog">Analogs</a>/other insulins</div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><i>fast-acting</i> (<a href="/wiki/Insulin_lispro" title="Insulin lispro">Insulin lispro</a></li>
<li><a href="/wiki/Insulin_aspart" title="Insulin aspart">Insulin aspart</a></li>
<li><a href="/wiki/Insulin_glulisine" title="Insulin glulisine">Insulin glulisine</a>)</li>
<li><i>short-acting</i> (<a href="/wiki/Insulin_therapy" title="Insulin therapy">Regular insulin</a>)</li>
<li><i>long-acting</i> (<a href="/wiki/Insulin_glargine" title="Insulin glargine">Insulin glargine</a></li>
<li><a href="/wiki/Insulin_detemir" title="Insulin detemir">Insulin detemir</a></li>
<li><a href="/wiki/NPH_insulin" title="NPH insulin">NPH insulin</a>)</li>
<li><i>ultra-long-acting</i> (<a href="/wiki/Insulin_degludec" title="Insulin degludec">Insulin degludec</a><sup>†</sup>)</li>
<li><i>inhalable</i> <a href="/wiki/Inhalable_insulin" title="Inhalable insulin">Exubera</a><sup>‡</sup></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:#fd6;;">Other</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Alpha-glucosidase_inhibitor" title="Alpha-glucosidase inhibitor">Alpha-glucosidase inhibitors</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Acarbose" title="Acarbose">Acarbose</a></li>
<li><a href="/wiki/Miglitol" title="Miglitol">Miglitol</a></li>
<li><a href="/wiki/Voglibose" title="Voglibose">Voglibose</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Amylin" title="Amylin">Amylin</a> analog</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Pramlintide" title="Pramlintide">Pramlintide</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Sodium-glucose_transport_proteins" title="Sodium-glucose transport proteins">SGLT2</a> <a href="/wiki/SGLT2_inhibitor" title="SGLT2 inhibitor" class="mw-redirect">inhibitors</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Canagliflozin" title="Canagliflozin">Canagliflozin</a></li>
<li><a href="/wiki/Dapagliflozin" title="Dapagliflozin">Dapagliflozin</a></li>
<li><a href="/wiki/Empagliflozin" title="Empagliflozin">Empagliflozin</a><sup>†</sup></li>
<li><a href="/wiki/Remogliflozin_etabonate" title="Remogliflozin etabonate">Remogliflozin</a><sup>§</sup></li>
<li><a href="/wiki/Sergliflozin_etabonate" title="Sergliflozin etabonate">Sergliflozin</a><sup>§</sup></li>
<li><a href="/wiki/Tofogliflozin" title="Tofogliflozin">Tofogliflozin</a><sup>†</sup></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:#fd6;;">
<div style="padding:0em 0.75em;">Other</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<ul>
<li><a href="/wiki/Bromocriptine" title="Bromocriptine">Bromocriptine</a></li>
<li><a href="/wiki/Benfluorex" title="Benfluorex">Benfluorex</a><sup>‡</sup></li>
<li><a href="/wiki/Tolrestat" title="Tolrestat">Tolrestat</a><sup>‡</sup></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px;">
<div style="padding:0em 0.25em;">
<div class="hlist">
<ul>
<li><sup>#</sup><a href="/wiki/List_of_World_Health_Organization_Essential_Medicines" title="List of World Health Organization Essential Medicines" class="mw-redirect">WHO-EM</a></li>
<li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li>
<li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>:
<ul>
<li><sup>†</sup><a href="/wiki/Clinical_trial#Phase_III" title="Clinical trial">Phase III</a></li>
<li><sup>§</sup><a href="/wiki/Clinical_trial#Phase_II" title="Clinical trial">Never to phase III</a></li>
</ul>
</li>
</ul>
</div>
</div>
</td>
</tr>
<tr style="height:2px;">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;;">
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="border-spacing:0;">
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px;background:transparent;color:inherit;;">
<div style="padding:0px;;">
<table cellspacing="0" class="navbox-columns-table" style="text-align:left;width:100%;">
<tr style="vertical-align:top;">
<td style="padding:0px;text-align:center;background:#efefef;;;text-align:center;background:#ccf;;width:10em;">
<div>
<p><a href="/wiki/Template:Medicine_navs" title="Template:Medicine navs">M</a>: <a href="/wiki/Endocrine_system" title="Endocrine system">END</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:white;;width:10em;">
<div>
<p><a href="/wiki/Template:Endocrine_system_anatomy" title="Template:Endocrine system anatomy">anat</a>/<a href="/wiki/Template:Endocrinology_physiology" title="Template:Endocrinology physiology">phys</a>/<a href="/wiki/Template:Embryology_of_endocrine_system" title="Template:Embryology of endocrine system">devp</a>/<a href="/wiki/Template:Hormones" title="Template:Hormones">horm</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:silver;;width:10em;">
<div>
<p><a href="/wiki/Template:Endocrine_pathology" title="Template:Endocrine pathology">noco</a> (<a href="/wiki/Template:Diabetes" title="Template:Diabetes">d</a>)/<a href="/wiki/Template:Congenital_endocrine_disorders" title="Template:Congenital endocrine disorders">cong</a>/<a href="/wiki/Template:Endocrine_gland_neoplasia" title="Template:Endocrine gland neoplasia">tumr</a>, <a href="/wiki/Template:Symptoms_concerning_nutrition,_metabolism_and_development" title="Template:Symptoms concerning nutrition, metabolism and development">sysi</a>/<a href="/wiki/Template:Eponymous_medical_signs_for_endocrinology,_nutrition,_and_metabolism" title="Template:Eponymous medical signs for endocrinology, nutrition, and metabolism">epon</a></p>
</div>
</td>
<td style="border-left:2px solid #fdfdfd;padding:0px;text-align:center;background:#efefef;;;text-align:center;background:#ccf;;width:10em;">
<div>
<p><a href="/wiki/Template:Endocrine_system_procedures" title="Template:Endocrine system procedures">proc</a>, <a href="/wiki/ATC_code_A" title="ATC code A">drug</a> (<a href="/wiki/Template:Oral_hypoglycemics_and_insulin_analogs" title="Template:Oral hypoglycemics and insulin analogs">A10</a>/<a href="/wiki/Template:Pituitary_and_hypothalamic_hormones_and_analogues" title="Template:Pituitary and hypothalamic hormones and analogues">H1</a>/<a href="/wiki/Template:Corticosteroids" title="Template:Corticosteroids">H2</a>/<a href="/wiki/Template:Thyroid_therapy" title="Template:Thyroid therapy">H3</a>/<a href="/wiki/Template:Calcium_homeostasis" title="Template:Calcium homeostasis">H5</a>)</p>
</div>
</td>
</tr>
</table>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<p><span id="interwiki-es-ga"></span> <span id="interwiki-ru-ga"></span></p>


<!-- 
NewPP limit report
Parsed by mw1217
CPU time usage: 4.296 seconds
Real time usage: 4.459 seconds
Preprocessor visited node count: 24914/1000000
Preprocessor generated node count: 58970/1500000
Post‐expand include size: 291195/2048000 bytes
Template argument size: 69108/2048000 bytes
Highest expansion depth: 16/40
Expensive parser function count: 5/500
Lua time usage: 0.105/10.000 seconds
Lua memory usage: 2.85 MB/50 MB
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:253720-0!*!0!!en!4!* and timestamp 20140325204922
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>								<div class="printfooter">
				Retrieved from "<a href="http://en.wikipedia.org/w/index.php?title=Metformin&amp;oldid=598885765">http://en.wikipedia.org/w/index.php?title=Metformin&amp;oldid=598885765</a>"				</div>
												<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Guanidines" title="Category:Guanidines">Guanidines</a></li><li><a href="/wiki/Category:World_Health_Organization_essential_medicines" title="Category:World Health Organization essential medicines">World Health Organization essential medicines</a></li><li><a href="/wiki/Category:Biguanides" title="Category:Biguanides">Biguanides</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Pages_containing_cite_templates_with_deprecated_parameters" title="Category:Pages containing cite templates with deprecated parameters">Pages containing cite templates with deprecated parameters</a></li><li><a href="/wiki/Category:Good_articles" title="Category:Good articles">Good articles</a></li><li><a href="/wiki/Category:Articles_containing_unverified_chemical_infoboxes" title="Category:Articles containing unverified chemical infoboxes">Articles containing unverified chemical infoboxes</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2010" title="Category:Articles containing potentially dated statements from 2010">Articles containing potentially dated statements from 2010</a></li><li><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2009" title="Category:Articles containing potentially dated statements from 2009">Articles containing potentially dated statements from 2009</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_March_2011" title="Category:Articles with unsourced statements from March 2011">Articles with unsourced statements from March 2011</a></li><li><a href="/wiki/Category:Articles_using_fixed_number_of_columns_in_reflist" title="Category:Articles using fixed number of columns in reflist">Articles using fixed number of columns in reflist</a></li><li><a href="/wiki/Category:Articles_with_Open_Directory_Project_links" title="Category:Articles with Open Directory Project links">Articles with Open Directory Project links</a></li></ul></div></div>												<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>
			<div id="mw-head">
				<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
	<h3 id="p-personal-label">Personal tools</h3>
	<ul>
<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Metformin&amp;type=signup">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Metformin" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>	</ul>
</div>
				<div id="left-navigation">
					<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
	<h3 id="p-namespaces-label">Namespaces</h3>
	<ul>
					<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Metformin"  title="View the content page [c]" accesskey="c">Article</a></span></li>
					<li  id="ca-talk"><span><a href="/wiki/Talk:Metformin"  title="Discussion about the content page [t]" accesskey="t">Talk</a></span></li>
			</ul>
</div>
<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
	<h3 id="mw-vector-current-variant">
		</h3>
	<h3 id="p-variants-label"><span>Variants</span><a href="#"></a></h3>
	<div class="menu">
		<ul>
					</ul>
	</div>
</div>
				</div>
				<div id="right-navigation">
					<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
	<h3 id="p-views-label">Views</h3>
	<ul>
					<li id="ca-view" class="selected"><span><a href="/wiki/Metformin" >Read</a></span></li>
					<li id="ca-edit"><span><a href="/w/index.php?title=Metformin&amp;action=edit"  title="You can edit this page. &#10;Please review your changes before saving. [e]" accesskey="e">Edit</a></span></li>
					<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Metformin&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
			</ul>
</div>
<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
	<h3 id="p-cactions-label"><span>Actions</span><a href="#"></a></h3>
	<div class="menu">
		<ul>
					</ul>
	</div>
</div>
<div id="p-search" role="search">
	<h3><label for="searchInput">Search</label></h3>
	<form action="/w/index.php" id="searchform">
					<div id="simpleSearch">
					<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />		</div>
	</form>
</div>
				</div>
			</div>
			<div id="mw-panel">
					<div id="p-logo" role="banner"><a style="background-image: url(//upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
				<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
	<h3 id='p-navigation-label'>Navigation</h3>
	<div class="body">
		<ul>
			<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
			<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
			<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li>
			<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
			<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			<li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li>
			<li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikimedia Shop</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
	<h3 id='p-interaction-label'>Interaction</h3>
	<div class="body">
		<ul>
			<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
			<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
			<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
			<li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
	<h3 id='p-tb-label'>Tools</h3>
	<div class="body">
		<ul>
			<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Metformin" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
			<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Metformin" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
			<li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li>
			<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li>
			<li id="t-permalink"><a href="/w/index.php?title=Metformin&amp;oldid=598885765" title="Permanent link to this revision of the page">Permanent link</a></li>
			<li id="t-info"><a href="/w/index.php?title=Metformin&amp;action=info">Page information</a></li>
			<li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q19484" title="Link to connected data repository item [g]" accesskey="g">Data item</a></li>
<li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Metformin&amp;id=598885765" title="Information on how to cite this page">Cite this page</a></li>		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
	<h3 id='p-coll-print_export-label'>Print/export</h3>
	<div class="body">
		<ul>
			<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Metformin">Create a book</a></li>
			<li id="coll-download-as-rl"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Metformin&amp;oldid=598885765&amp;writer=rl">Download as PDF</a></li>
			<li id="t-print"><a href="/w/index.php?title=Metformin&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>
		</ul>
	</div>
</div>
<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
	<h3 id='p-lang-label'>Languages</h3>
	<div class="body">
		<ul>
			<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D9%85%D9%8A%D8%AA%D9%81%D9%88%D8%B1%D9%85%D9%8A%D9%86" title="ميتفورمين – Arabic" lang="ar" hreflang="ar">العربية</a></li>
			<li class="interlanguage-link interwiki-bn"><a href="//bn.wikipedia.org/wiki/%E0%A6%AE%E0%A7%87%E0%A6%9F%E0%A6%AB%E0%A6%B0%E0%A6%AE%E0%A6%BF%E0%A6%A8" title="মেটফরমিন – Bengali" lang="bn" hreflang="bn">বাংলা</a></li>
			<li class="interlanguage-link interwiki-da"><a href="//da.wikipedia.org/wiki/Metformin" title="Metformin – Danish" lang="da" hreflang="da">Dansk</a></li>
			<li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Metformin" title="Metformin – German" lang="de" hreflang="de">Deutsch</a></li>
			<li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Metformina" title="Metformina – Spanish" lang="es" hreflang="es">Español</a></li>
			<li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%85%D8%AA%D9%81%D9%88%D8%B1%D9%85%DB%8C%D9%86" title="متفورمین – Persian" lang="fa" hreflang="fa">فارسی</a></li>
			<li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Metformine" title="Metformine – French" lang="fr" hreflang="fr">Français</a></li>
			<li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%EB%A9%94%ED%8A%B8%ED%8F%AC%EB%AF%BC" title="메트포민 – Korean" lang="ko" hreflang="ko">한국어</a></li>
			<li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Metformina" title="Metformina – Italian" lang="it" hreflang="it">Italiano</a></li>
			<li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%9E%D7%98%D7%A4%D7%95%D7%A8%D7%9E%D7%99%D7%9F" title="מטפורמין – Hebrew" lang="he" hreflang="he">עברית</a></li>
			<li class="interlanguage-link interwiki-hu"><a href="//hu.wikipedia.org/wiki/Metformin" title="Metformin – Hungarian" lang="hu" hreflang="hu">Magyar</a></li>
			<li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Metformine" title="Metformine – Dutch" lang="nl" hreflang="nl">Nederlands</a></li>
			<li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E3%83%A1%E3%83%88%E3%83%9B%E3%83%AB%E3%83%9F%E3%83%B3" title="メトホルミン – Japanese" lang="ja" hreflang="ja">日本語</a></li>
			<li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Metformina" title="Metformina – Polish" lang="pl" hreflang="pl">Polski</a></li>
			<li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Metformina" title="Metformina – Portuguese" lang="pt" hreflang="pt">Português</a></li>
			<li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%9C%D0%B5%D1%82%D1%84%D0%BE%D1%80%D0%BC%D0%B8%D0%BD" title="Метформин – Russian" lang="ru" hreflang="ru">Русский</a></li>
			<li class="interlanguage-link interwiki-sq"><a href="//sq.wikipedia.org/wiki/Metformin" title="Metformin – Albanian" lang="sq" hreflang="sq">Shqip</a></li>
			<li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/Metformin" title="Metformin – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li>
			<li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Metformiini" title="Metformiini – Finnish" lang="fi" hreflang="fi">Suomi</a></li>
			<li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Metformin" title="Metformin – Swedish" lang="sv" hreflang="sv">Svenska</a></li>
			<li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B9%80%E0%B8%A1%E0%B8%95%E0%B8%9F%E0%B8%AD%E0%B8%A3%E0%B9%8C%E0%B8%A1%E0%B8%B4%E0%B8%99" title="เมตฟอร์มิน – Thai" lang="th" hreflang="th">ไทย</a></li>
			<li class="uls-p-lang-dummy"><a href="#"></a></li>
			<li class="wbc-editpage"><a href="//www.wikidata.org/wiki/Q19484#sitelinks-wikipedia" title="Edit interlanguage links">Edit links</a></li>
		</ul>
	</div>
</div>
			</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 25 March 2014 at 20:49.<br /></li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy.</a> <br/>
Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a class="external" href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/wiki/Metformin" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
					<li id="footer-copyrightico">
						<a href="//wikimediafoundation.org/"><img src="//bits.wikimedia.org/images/wikimedia-button.png" width="88" height="31" alt="Wikimedia Foundation"/></a>
					</li>
					<li id="footer-poweredbyico">
						<a href="//www.mediawiki.org/"><img src="//bits.wikimedia.org/static-1.23wmf19/skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" width="88" height="31" /></a>
					</li>
				</ul>
						<div style="clear:both"></div>
		</div>
		<script>/*<![CDATA[*/window.jQuery && jQuery.ready();/*]]>*/</script><script>if(window.mw){
mw.loader.state({"site":"loading","user":"ready","user.groups":"ready"});
}</script>
<script>if(window.mw){
mw.loader.load(["ext.cite","mobile.desktop","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.DRN-wizard","ext.gadget.charinsert","mw.MwEmbedSupport.style","ext.navigationTiming","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage","skins.vector.collapsibleNav"],null,true);
}</script>
<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=scripts&amp;skin=vector&amp;*"></script>
<!-- Served by mw1066 in 0.409 secs. -->
	</body>
</html>
